Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3021387	s-prl	mU/l (mu/l)	16501	27645	0.15%
3021387	s-prl	— (—)	2777	3701	100.00%	Distribution not available
3021387	s-prl	mIU/l (mu/l)	1529	1647	0.00%
3021387	s-prl	mU/l______ (mu/l)	376	585	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Unspecified mental disorder

2149

9016

2.53

318.29

2.0

1.6

563.52

270.78

mu/l

39.37

1896

8208

Other antidepressants

3942

10120

2.05

314.29

1.7

326.28

281.65

mu/l

7.64

3546

9285

Kela-code for severe mental illness

1894

7604

2.65

308.73

2.1

1.7

597.72

271.19

mu/l

38.66

1662

6925

Panhypopituitarism

360

204

36.38

307.65

4.9

1.5

396.74

267.66

mu/l

4.72

350

190

Testicular hypofunction

487

338

20.89

307.65

1.7

1.4

246.95

254.58

mu/l

0.15

464

319

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1293

838

36.90

307.65

5.0

1.4

381.31

288.85

mu/l

3.53

1271

763

Testicular dysfunction

533

368

20.65

307.65

1.7

1.4

245.71

256.02

mu/l

0.23

509

349

Anxiety disorders, excluding more controls

3727

10370

2.39

307.65

1.8

1.6

343.29

265.98

mu/l

18.17

3347

9495

Hypothyroidism (congenital or acquired)

1922

3869

3.01

307.65

2.1

1.5

333.87

264.64

mu/l

7.99

1716

3552

Female infertility, associated with anovulation

1162

2292

6.71

307.65

1.7

1.6

260.22

375.51

mu/l

10.29

1070

1966

Hypothyroidism and >3 levothyroxin purchases

1906

3865

2.99

307.65

2.1

1.5

334.44

264.66

mu/l

8.05

1702

3549

Other anxiety disorders

3052

11738

2.36

307.65

1.7

1.6

380.38

284.86

mu/l

10.86

2703

10641

All anxiety disorders

3812

12797

2.45

307.65

1.7

1.6

361.52

284.34

mu/l

10.58

3388

11633

Mood [affective] disorders

4790

13841

2.31

307.65

1.7

360.06

278.62

mu/l

24.58

4265

12650

Hyperprolactinaemia

739

832

16.97

307.65

6.3

1.4

712.34

290.27

mu/l

11.58

713

750

Exclusions for E4_PCOS_CONSORTIUM

4151

11584

2.37

307.65

2.9

1.3

370.59

288.27

mu/l

15.41

3865

10343

Hyperfunction of pituitary gland

902

1071

13.91

307.65

6.0

1.4

637.41

288.56

mu/l

11.62

873

959

Female infertility

2909

3665

5.60

307.65

1.6

1.7

274.93

380.74

mu/l

11.81

2643

3152

Noninflammatory disorders of female genital tract

2314

4294

2.89

307.65

1.6

1.7

297.15

381.72

mu/l

8.83

2096

3714

Hypothyroidism, levothyroxine purchases

1906

3865

2.99

307.65

2.1

1.5

334.44

264.66

mu/l

8.05

1702

3549

Neurotic, stress-related and somatoform disorders

4314

13800

2.25

307.65

1.8

1.6

350.16

285.55

mu/l

9.00

3860

12580

Hypogonadotropic hypogonadism

573

410

24.72

307.65

2.6

1.5

268.66

259.58

mu/l

0.22

559

385

Schizophrenia or delusion, excluding more controls

1652

5537

3.16

307.65

2.1

1.6

612.69

262.95

mu/l

61.92

1451

5083

Benign neoplasm of other and unspecified endocrine glands

1410

1535

11.76

307.65

4.8

1.4

376.64

294.09

mu/l

3.37

1374

1393

Use of cabergoline

340

272

31.48

307.65

8.7

1.4

533.93

286.40

mu/l

2.51

329

250

Mood disorders, excluding more controls

4086

10523

2.37

307.65

1.7

1.6

357.17

265.87

mu/l

26.16

3651

9636

Hypopituitarism

1312

1034

20.84

307.65

3.3

1.4

328.41

282.84

mu/l

3.23

1275

942

Disorders of other endocrine glands

4162

8249

5.77

307.65

2.9

1.4

367.57

292.77

mu/l

8.76

3962

7366

Irregular menses

3389

10328

2.67

307.65

1.8

1.6

304.27

327.04

mu/l

2.19

3109

9108

Anxiety (asthma-related co-morbidities)

3650

11185

2.64

307.65

1.7

1.6

358.25

266.13

mu/l

14.06

3250

10215

Polycystic ovarian syndrome, consortium definition

4050

10599

2.32

307.65

1.8

1.6

300.45

328.80

mu/l

3.59

3725

9358

Depression

4636

13737

2.36

307.65

1.7

354.00

278.62

mu/l

13.68

4126

12554

Recurrent or chronic depression

1878

4719

2.90

307.65

1.6

1.7

293.63

278.46

mu/l

0.80

1700

4370

Medical treatment for female infertility

1982

7829

2.86

307.65

1.6

274.39

313.66

mu/l

8.45

1777

6970

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2677

5476

5.59

307.65

3.4

1.4

352.61

300.42

mu/l

2.65

2563

4915

Mood disorders

4795

13840

2.31

307.65

1.7

360.61

278.42

mu/l

24.93

4270

12650

Exclusions for E4_PCOS_BROAD

2753

3065

12.91

307.65

3.8

1.3

423.06

283.51

mu/l

14.42

2662

2767

Endocrine, nutritional and metabolic diseases

4195

9132

2.43

307.65

2.0

1.3

326.92

279.88

mu/l

6.43

3830

8204

Anxiety disorders

4329

13808

2.24

307.65

1.8

1.6

349.27

285.64

mu/l

8.80

3873

12587

Polycystic ovarian syndrome, broad definition

1521

4789

4.01

307.65

1.5

1.3

260.98

296.47

mu/l

5.43

1396

4206

Amenorrhoea

916

1686

7.09

307.65

2.2

1.6

320.78

383.73

mu/l

1.91

855

1444

Female infertility, cervical, vaginal, other or unspecified origin

2626

3527

5.59

307.65

1.5

1.7

273.71

380.42

mu/l

11.37

2379

3035

Ovarian dysfunction

1011

3133

4.07

285.37

1.8

1.3

280.11

296.39

mu/l

0.91

949

2761

Behavioural syndromes associated with physiological disturbances and physical factors

3958

14331

1.93

283.97

1.6

1.7

307.99

303.87

mu/l

0.22

3532

13062

Selective serotonin reuptake inhibitors

3777

10161

1.99

279.39

1.7

321.12

281.84

mu/l

7.03

3387

9326

Disorders of the thyroid gland

3918

13659

1.92

274.77

2.1

1.6

339.41

298.22

mu/l

4.30

3517

12361

Used for control exclusion in common control thyroid runs

4333

12014

1.87

265.81

2.2

1.4

318.54

293.59

mu/l

2.26

3973

10824

Hypothyroidism, other/unspecified

3709

13065

1.93

263.68

2.1

1.5

337.19

300.51

mu/l

5.87

3320

11815

Schizophrenia or delusion

1652

6705

2.62

263.53

2.1

1.7

612.69

266.33

mu/l

63.58

1451

6128

Schizophrenia, schizotypal and delusional disorders

1651

6710

2.62

262.55

2.1

1.7

612.66

266.35

mu/l

63.56

1451

6131

Other and unspecified nonorganic psychotic disorders

1304

4790

2.98

258.19

2.2

1.7

633.51

268.31

mu/l

52.62

1144

4377

Hypothyreosis and Thyroxine purchase for inclusion criteria

3768

13496

1.89

251.08

2.1

1.6

336.68

302.02

mu/l

5.11

3373

12200

Sleep disorders

3756

14179

1.88

250.97

1.6

1.7

303.82

303.90

mu/l

0.00

3347

12913

Polycystic ovarian syndrome

840

2560

4.31

247.14

1.8

1.3

281.26

295.59

mu/l

0.76

785

2258

Depression or dysthymia

2158

5181

2.34

243.87

1.7

284.05

277.80

mu/l

0.28

1946

4811

Personality disorders, excluding more controls

1611

6710

2.57

243.46

1.9

1.6

441.66

266.16

mu/l

11.99

1408

6116

Excessive, frequent and irregular menstruation

1897

4278

2.49

236.93

1.6

1.7

302.37

381.95

mu/l

7.32

1713

3698

Insomnia

3750

14709

1.83

229.32

1.6

1.7

300.53

306.10

mu/l

0.34

3342

13377

Any mental disorder

3806

10548

1.85

227.49

1.7

1.6

339.34

266.16

mu/l

19.79

3434

9661

Genitourinary diseases

2141

4931

2.25

214.08

1.7

1.8

285.94

310.94

mu/l

2.57

1983

4463

Depression medications

1828

3995

2.43

211.58

1.7

1.5

319.07

264.71

mu/l

5.57

1654

3674

Other nutritional deficiencies

2927

14842

1.86

198.92

1.7

302.78

307.55

mu/l

0.29

2645

13424

Disorders of adult personality and behaviour

1812

8679

2.23

198.18

1.9

1.6

429.35

298.46

mu/l

8.67

1594

7856

Thyrotropin deficiency

200

198

18.01

193.84

3.6

1.5

419.84

287.14

mu/l

3.66

191

178

Headache

2836

12091

1.87

190.10

1.8

1.6

321.62

297.89

mu/l

1.14

2582

10959

Psychiatric diseases

3188

8864

1.84

188.47

1.7

322.85

269.55

mu/l

10.39

2872

8158

Sleep disorders (combined)

3978

12375

1.72

187.31

1.7

304.31

307.46

mu/l

0.17

3544

11287

Pain and other conditions associated with female genital organs and menstrual cycle

1195

4098

2.60

180.16

1.6

1.7

310.62

381.87

mu/l

4.50

1060

3534

Migraine

2610

11429

1.85

166.27

1.7

1.6

314.98

311.64

mu/l

0.15

2369

10297

Oligomenorrhoea

323

626

6.23

164.94

1.9

1.8

303.76

365.59

mu/l

1.89

296

540

Other disorders of adrenal gland

319

619

5.99

161.08

2.6

1.4

356.61

299.15

mu/l

2.12

297

555

Personality disorders

1611

7984

2.15

160.52

1.9

1.6

441.66

295.07

mu/l

8.59

1408

7232

Obesity and other hyperalimentation

2688

14603

1.79

160.09

1.7

304.34

307.13

mu/l

0.15

2429

13212

Obesity

2679

14579

1.79

159.47

1.7

304.52

307.20

mu/l

0.14

2420

13189

Bipolar affective disorders

1113

4771

2.50

159.16

1.9

1.6

452.29

282.63

mu/l

16.58

1004

4336

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1543

7427

2.17

158.98

1.8

1.6

438.38

267.57

mu/l

22.52

1348

6742

Episodal and paroxysmal disorders

4119

13123

1.63

156.95

1.7

1.6

311.19

307.37

mu/l

0.21

3716

11885

Specific personality disorders

1450

7019

2.21

154.46

1.9

1.6

415.36

292.50

mu/l

14.87

1264

6344

Procreative management

1562

6275

2.15

154.18

1.8

277.27

332.21

mu/l

7.08

1487

5674

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3654

14586

1.64

151.82

1.8

1.7

304.18

306.19

mu/l

0.10

3325

13194

Persons encountering health services in other circumstances, wide

3878

12484

1.63

149.49

1.7

335.82

288.40

mu/l

5.22

3522

11357

Adrenocortical insufficiency

256

438

6.86

147.93

2.6

1.3

345.08

287.12

mu/l

2.12

238

398

General symptoms and signs

3971

12560

1.62

147.65

1.7

1.6

312.37

295.81

mu/l

1.64

3586

11396

Habitual aborter

258

478

7.08

141.22

1.4

1.7

261.88

359.70

mu/l

4.71

239

424

Medical observation and evaluation for suspected diseases and conditions

2381

6778

1.84

140.71

1.8

1.6

320.88

286.32

mu/l

3.75

2165

6042

Schizophrenia

741

2783

2.84

138.86

2.2

1.7

666.54

258.32

mu/l

36.34

640

2560

Nonorganic sleeping disorders, excluding more controls

1067

4780

2.36

136.46

1.7

1.6

363.93

268.86

mu/l

6.91

947

4349

Benzodiazepine use

3579

15448

1.60

134.17

1.8

1.7

398.25

283.40

mu/l

17.86

3169

14070

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3691

12481

1.60

134.16

1.7

334.40

288.17

mu/l

4.73

3427

11354

Dentofacial anomalies [including malocclusion]

3003

14629

1.65

130.84

1.6

1.7

297.36

309.30

mu/l

0.53

2722

13207

Sleep apnoea

2652

10091

1.69

123.38

1.8

1.7

296.36

301.66

mu/l

0.28

2372

9224

Malaise and fatigue

1651

6932

1.92

122.94

1.8

1.7

342.85

296.28

mu/l

3.54

1500

6298

Persons encountering health services in other circumstances

1651

8866

1.90

122.48

1.8

1.7

393.17

286.27

mu/l

12.49

1336

8015

Hypothyroidism, strict autoimmune

2623

10486

1.68

119.70

1.6

1.4

329.21

297.03

mu/l

4.19

2301

9394

Acute upper respiratory infections of multiple and unspecified sites

2925

13437

1.62

119.26

1.7

309.48

306.67

mu/l

0.14

2631

12164

Neurological diseases

3388

10956

1.59

116.40

1.7

1.6

304.93

306.97

mu/l

0.10

3080

9917

Sleep apnoea, including avohilmo

2963

11363

1.60

112.29

1.8

1.7

293.92

306.64

mu/l

0.93

2647

10363

Obesity due to excess calories

1991

11887

1.73

106.99

1.7

1.6

299.83

304.70

mu/l

0.26

1810

10732

Non-selective monoamine reuptake inhibitors

807

3373

2.35

106.56

1.7

1.8

360.45

278.88

mu/l

4.97

708

3114

Schizoaffective disorder

450

1516

3.27

104.95

2.3

1.6

684.11

263.21

mu/l

23.31

404

1384

Emotionally unstable personality disorder

907

4301

2.30

104.06

1.9

1.6

441.06

297.79

mu/l

11.36

784

3870

Disorders of pituitary gland, other and/or unspecified

22.55

102.41

4.4

1.2

330.32

285.63

mu/l

0.51

Benign neoplasms

3745

13919

1.49

99.43

2.3

1.4

317.74

298.67

mu/l

1.18

3475

12490

Other reaction to severe stress, and adjustment disorders

1728

10157

1.76

98.67

1.8

1.6

357.37

284.80

mu/l

3.29

1539

9195

KRA_PSY_EATING, excluding more controls

758

3465

2.42

94.41

1.8

1.5

363.57

279.19

mu/l

4.66

661

3110

Pain in joint

2015

7504

1.68

92.51

1.7

279.54

308.11

mu/l

3.15

1838

6798

General examination and investigation of persons without complaint and reported diagnosis

2141

6778

1.67

92.46

1.7

1.6

333.14

286.32

mu/l

5.55

2005

6042

Other headache syndromes

1538

8872

1.78

91.97

1.8

1.6

290.78

306.74

mu/l

1.16

1404

8017

Endometriosis of pelvic peritoneum

639

2449

2.49

91.83

1.6

1.7

316.59

391.83

mu/l

2.59

581

2119

Endometriosis

1194

3612

1.98

90.67

1.6

1.7

301.91

382.11

mu/l

5.53

1082

3117

Hyperkinetic disorders, excluding more controls

1015

4899

2.08

90.34

1.6

1.5

318.64

270.63

mu/l

3.20

897

4428

Poisoning by drugs, medicaments and biological substances

1172

6332

1.94

90.15

1.8

1.7

448.15

296.35

mu/l

12.84

1013

5752

Ovarian cyst

1273

3880

1.94

89.84

1.6

1.7

283.45

381.28

mu/l

9.45

1145

3352

Anaemias

1103

3656

2.01

88.01

1.7

1.5

317.62

265.04

mu/l

3.92

1002

3354

Neurological diseases, wide definition

1569

4483

1.82

87.77

1.7

1.6

309.10

315.38

mu/l

0.21

1437

4003

Unspecified/other endometriosis

517

2004

2.72

87.73

1.5

1.7

302.37

389.22

mu/l

2.93

468

1728

Asthma (mode)

2637

9011

1.57

87.44

1.7

309.97

304.51

mu/l

0.27

2413

8161

Endocrine disorders, other/unspecified

144

239

7.22

86.36

3.8

1.3

324.52

303.16

mu/l

0.36

127

215

Intestinal infectious diseases, including avohilmo, including avohilmo

3666

14285

1.45

85.67

1.8

1.7

305.14

305.97

mu/l

0.04

3350

12927

Symptoms and signs involving the nervous and musculoskeletal systems

1716

10407

1.68

85.58

1.8

1.7

312.47

303.80

mu/l

0.40

1580

9419

Symptoms and signs involving the circulatory and respiratory systems

3752

13180

1.45

85.44

1.7

309.91

304.87

mu/l

0.29

3403

11919

Other menopausal disorders

684

1614

2.43

85.15

1.6

1.8

276.95

396.19

mu/l

5.95

631

1420

Substance abuse, excluding more controls

1679

8409

1.70

85.14

1.8

1.7

399.53

262.19

mu/l

19.69

1469

7723

Disorders of parathyroid gland

381

1273

3.04

84.79

2.8

1.3

350.40

296.03

mu/l

1.18

363

1151

Generalized anxiety disorder

1063

5697

1.98

84.72

1.7

1.6

347.37

290.54

mu/l

3.62

944

5124

Asthma

2651

8966

1.55

84.44

1.7

310.22

304.29

mu/l

0.30

2429

8120

Acute and transient psychotic disorders

508

2028

2.66

84.43

2.2

1.7

635.96

263.50

mu/l

23.77

457

1854

Obesity related asthma

1056

5597

1.94

84.35

1.8

1.7

300.77

295.92

mu/l

0.18

972

5088

Neoplasms

3415

12414

1.47

84.25

2.1

1.4

314.03

301.81

mu/l

0.58

3155

11111

Dysplasia of cervi uteri

948

3345

2.07

83.90

1.5

1.7

289.16

381.80

mu/l

5.62

863

2872

Asthma, excluding more controls

2630

8853

1.55

83.85

1.7

310.79

304.30

mu/l

0.33

2409

8019

Poisoning by medicine

1072

5772

1.95

83.51

1.8

1.7

457.64

296.76

mu/l

12.63

929

5242

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1543

9248

1.74

83.26

1.8

1.6

438.38

296.24

mu/l

15.98

1348

8342

Migraine, single triptan purchase ok & required. ICD-code if available is included

2981

13788

1.50

83.24

1.7

297.49

311.43

mu/l

1.08

2723

12447

Triptan medication for migraine, single purchase ok

2981

13788

1.50

83.24

1.7

297.49

311.43

mu/l

1.08

2723

12447

Dental pulpitis, including avohilmo

3462

15562

1.45

82.50

1.8

1.7

315.73

302.61

mu/l

1.05

3051

14182

Diseases of male genital organs

1195

3184

1.93

82.15

1.7

1.9

261.40

262.38

mu/l

0.04

1129

3011

Examination and observation for other reasons

1942

6768

1.65

81.35

1.7

1.6

312.41

286.50

mu/l

2.47

1813

6032

Bronchitis

3644

15480

1.43

80.98

1.7

304.51

306.27

mu/l

0.10

3266

14045

Other specified and unspecified personality disorders

500

2052

2.64

79.50

1.9

1.6

452.44

284.64

mu/l

8.58

445

1859

Cystitis

2843

11472

1.50

79.43

1.6

1.7

315.54

310.88

mu/l

0.15

2536

10344

Opioids

3632

13272

1.44

79.10

1.7

296.41

305.60

mu/l

0.72

3274

12000

Male infertility

240

650

4.04

78.62

1.9

1.8

244.09

257.10

mu/l

0.40

235

620

Intestinal infectious diseases

3188

16611

1.45

78.09

1.8

1.7

320.02

302.14

mu/l

1.52

2909

15043

Nonorganic sleeping disorders

1067

5863

1.91

77.90

1.7

363.93

305.24

mu/l

2.99

947

5297

Visual disturbances and blindness

1557

9444

1.68

77.55

2.2

1.7

333.63

305.61

mu/l

0.72

1432

8562

Visual disturbances

1490

8978

1.70

76.63

2.2

1.7

330.89

306.34

mu/l

0.57

1371

8137

Abdominal and pelvic pain

3153

10966

1.46

76.23

1.7

301.09

305.49

mu/l

0.23

2878

10000

Hypertrichosis

257

776

4.18

76.06

1.7

1.6

308.52

303.58

mu/l

0.12

249

692

Hyperparathyroidism

318

1021

3.16

75.99

3.0

1.3

355.10

301.21

mu/l

0.92

305

924

Panic disorder

895

4710

2.02

75.67

1.7

1.6

406.30

289.61

mu/l

2.52

791

4236

Suicide or other Intentional self-harm

1063

5879

1.88

75.55

1.9

1.7

476.90

292.80

mu/l

16.59

927

5346

Obesity, other/unspecified

1385

8263

1.73

74.97

1.8

1.6

299.06

307.14

mu/l

0.43

1230

7445

Pregnancy examination and test

1083

3679

1.95

74.82

1.6

1.8

286.48

366.77

mu/l

8.89

966

3239

Female infertility, tubal origin

243

686

3.86

74.81

1.6

1.7

296.57

371.66

mu/l

2.47

222

605

Caries of enamel

3204

14791

1.44

74.11

1.7

304.12

303.23

mu/l

0.04

2906

13403

Antihypertensive medication - note that there are other indications

3156

11575

1.46

73.42

1.7

1.6

336.36

297.90

mu/l

5.04

2879

10394

Acute upper respiratory infections

3264

13843

1.43

72.81

1.7

300.86

306.68

mu/l

0.39

2956

12543

Post-traumatic stress disorder

666

3229

2.25

72.50

1.8

1.6

378.01

293.20

mu/l

3.47

584

2899

Persistent mood disorders

673

3238

2.16

71.39

1.7

377.87

278.62

mu/l

6.61

606

2948

Endometriosis diagnosis and infertility diagnosis occurring together

624

2955

2.28

71.33

1.5

1.7

292.76

310.56

mu/l

0.80

572

2618

Any reimbursement code in KELA

2742

9422

1.49

71.17

1.8

1.5

336.33

269.33

mu/l

13.41

2471

8503

Hirsutism in women

234

698

4.29

70.92

1.7

1.6

314.27

291.44

mu/l

0.83

227

620

Other soft tissue disorders, not elsewhere classified

3344

13597

1.42

70.14

1.7

304.66

308.47

mu/l

0.22

3026

12281

Symptoms and signs involving the digestive system and abdomen

3116

10966

1.44

69.97

1.7

296.47

305.49

mu/l

0.63

2823

10000

Endometriosis of ovary

539

2243

2.35

69.72

1.7

291.27

375.24

mu/l

4.48

499

1940

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1629

9032

1.66

69.69

1.7

1.6

362.14

302.73

mu/l

5.53

1429

8140

Other disorders of fluid, electrolyte and acid-base balance

602

2624

2.20

68.58

2.3

1.7

384.81

284.31

mu/l

5.75

555

2402

Other obstetric conditions, not elsewhere classified

2293

9838

1.54

68.13

1.6

314.85

317.13

mu/l

0.05

2040

8782

Codeine

3332

12919

1.42

67.79

1.7

294.42

304.29

mu/l

0.76

2992

11682

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2272

9759

1.54

66.61

1.6

314.52

317.32

mu/l

0.06

2024

8711

Obsessive-compulsive disorder

528

2422

2.39

66.25

1.9

1.6

431.20

279.17

mu/l

9.79

476

2186

Asthma, including avohilmo

3880

15782

1.37

66.00

1.6

1.7

308.56

304.57

mu/l

0.24

3546

14274

Parasetamol

2803

9885

1.46

65.89

1.7

301.65

307.15

mu/l

0.31

2537

8972

Impotence

176

431

4.33

65.48

1.6

1.9

229.30

275.32

mu/l

1.62

160

411

Other special examinations and investigations of persons without complaint or reported diagnosis

2042

6778

1.55

64.99

1.8

1.6

298.71

286.32

mu/l

0.86

1875

6042

Mixed and other personality disorders

426

1784

2.58

64.87

2.0

1.7

520.86

281.22

mu/l

2.57

374

1629

Asthma (only as main-diagnosis)

2357

8966

1.49

64.16

1.7

314.83

304.29

mu/l

0.59

2164

8120

Pain, not elsewhere classified

957

5374

1.83

63.80

1.8

1.6

365.91

295.44

mu/l

1.37

874

4874

Complications associated with artificial fertilization

162

396

4.90

63.11

1.4

1.8

280.17

346.53

mu/l

1.80

148

344

Uterine polyps

688

1950

2.11

63.06

1.7

1.8

297.65

382.04

mu/l

3.92

634

1710

Asthma (only as main-diagnosis), excluding more controls

2347

8853

1.49

63.00

1.7

314.75

304.30

mu/l

0.58

2154

8019

Primary hyperparathyroidism

253

808

3.25

62.90

3.3

1.7

336.41

324.25

mu/l

0.12

242

734

Polyp of the female genital tract

761

2167

2.04

62.88

1.7

1.8

297.83

374.31

mu/l

4.00

702

1890

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1432

4372

1.68

62.32

1.7

1.6

293.92

300.32

mu/l

0.25

1294

3965

646

3238

2.09

62.16

1.8

1.7

339.91

285.86

mu/l

2.62

544

2905

Other symptoms and signs involving the nervous and musculoskeletal systems

1296

7988

1.66

61.17

1.8

1.7

315.27

305.70

mu/l

0.36

1197

7219

Gender identity disorders

180

499

4.72

61.14

2.0

1.6

367.60

311.42

mu/l

1.84

170

444

Eating disorder

762

4133

2.02

60.91

1.8

1.6

362.56

318.92

mu/l

1.59

665

3694

Pain (limb, back, neck, head abdominally)

2230

7563

1.50

60.76

1.7

297.60

308.18

mu/l

0.66

2048

6853

Dorsalgia

3469

13514

1.38

60.60

1.7

296.33

311.94

mu/l

1.42

3170

12214

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

816

4473

1.92

60.48

1.9

1.7

481.43

290.84

mu/l

14.18

709

4053

Substance use, excluding alcohol

806

4389

1.91

60.23

1.9

1.7

443.31

282.34

mu/l

12.28

694

4027

Special screening examination for infectious and parasitic diseases

1290

5773

1.68

59.93

1.5

1.6

315.00

283.10

mu/l

0.76

1186

5128

Fever of other and unknown origin

1714

9755

1.55

59.69

1.8

1.7

323.51

297.62

mu/l

1.77

1560

8855

Spontaneous abortion

1908

8552

1.53

59.62

1.5

1.7

286.56

327.62

mu/l

4.84

1680

7640

Other functional intestinal disorders

1257

7006

1.66

59.15

1.9

1.7

345.10

312.75

mu/l

1.48

1144

6333

Disease of hard tissues of teeth, NOS

1279

4012

1.69

59.02

1.7

1.8

298.51

299.83

mu/l

0.04

1177

3670

Dental caries

707

3477

1.97

58.82

2.0

1.7

355.38

295.08

mu/l

2.72

647

3178

Triptan medication for migraine, min. 3 purchases

2544

13529

1.44

58.68

1.6

313.63

312.02

mu/l

0.07

2335

12118

Atopic dermatitis

2491

14087

1.44

58.27

1.6

1.7

297.40

308.53

mu/l

0.82

2246

12724

Other abnormal products of conception

1804

7898

1.55

58.16

1.5

1.6

274.05

324.58

mu/l

9.08

1640

7039

Eating disorders

787

4359

1.95

57.98

1.8

1.6

358.26

314.51

mu/l

1.66

688

3903

Codeine or tramadol medication

3651

14809

1.36

57.82

1.7

294.18

303.40

mu/l

0.75

3284

13407

Phobic anxiety disorders

786

4325

1.91

57.44

1.8

1.6

357.09

288.16

mu/l

4.20

690

3911

Other dorsopathies, not elsewhere classified

3517

13567

1.36

57.39

1.7

294.04

312.37

mu/l

1.81

3207

12263

Other diseases of urinary system

3078

12593

1.39

57.28

1.7

313.59

305.34

mu/l

0.32

2771

11412

Use of hypnotics and sedatives

3062

12760

1.39

56.89

1.7

343.49

291.52

mu/l

7.24

2767

11604

Persons encountering health services in circumstances related to reproduction

1788

7972

1.53

56.63

1.7

1.8

278.83

323.61

mu/l

6.01

1656

7257

Hypothyroidism, strict autoimmune, 3 medication purchases required

2653

12785

1.41

56.33

1.5

1.6

327.88

303.40

mu/l

2.40

2324

11550

Other noninflammatory disorders of vulva and perineum

358

1464

2.56

56.32

1.7

299.74

367.62

mu/l

1.62

315

1267

Drug-induced adrenocortical insufficiency

115

231

5.75

56.10

1.8

1.5

334.58

272.80

mu/l

2.05

106

215

Implicit viral Sepsis, including avohilmo

771

4211

1.87

55.58

2.0

1.7

341.62

288.22

mu/l

3.16

696

3845

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

772

4234

1.87

55.41

1.7

1.8

341.29

280.52

mu/l

0.84

695

3900

Glucagon-like peptide-1 (GLP-1) analogues

772

4234

1.87

55.41

1.7

1.8

341.29

280.52

mu/l

0.84

695

3900

Factors influencing health status and contact with health services

718

1837

1.99

55.02

1.7

279.22

284.01

mu/l

0.16

665

1676

Care involving use of rehabilitation procedures

1745

10540

1.51

54.91

1.8

1.7

316.61

297.85

mu/l

1.14

1594

9579

Mycoses, including avohilmo

2999

16862

1.37

54.23

1.7

321.74

302.66

mu/l

0.88

2714

15288

Non-invasive ventilation

735

3439

1.89

53.48

1.8

1.6

230.21

270.58

mu/l

3.12

709

3140

Exposure to unspecified factor

3273

16665

1.35

53.10

1.7

330.83

300.48

mu/l

3.32

2905

15172

Visual field defects

251

883

2.98

53.09

3.8

1.6

343.00

299.38

mu/l

0.89

239

811

Disorders of tooth development and eruption

663

2843

1.97

52.74

1.6

1.7

287.05

299.94

mu/l

0.50

597

2578

Irritable bowel syndrome

999

6007

1.71

52.48

1.8

1.7

303.96

311.96

mu/l

0.25

892

5382

Menorrhagia

954

3059

1.78

52.36

1.6

1.7

299.73

384.97

mu/l

4.90

862

2636

Persons encountering health services for examination and investigation

1981

6778

1.49

52.04

1.7

1.6

290.08

286.32

mu/l

0.22

1807

6042

Emotional disorders starting during childhood or adolecense, excluding more controls

379

1630

2.51

51.79

2.1

1.5

440.30

287.14

mu/l

4.56

324

1460

Viral hepatitis, IBD co-morbidity

267

990

2.88

51.79

1.8

403.27

278.39

mu/l

3.56

222

900

Hypo-osmolality and hyponatraemia

312

1228

2.58

51.34

2.5

1.7

393.52

285.97

mu/l

3.62

287

1136

Other and unspecified mood [affective] disorders

448

2124

2.27

51.25

1.9

1.6

462.29

275.16

mu/l

10.14

405

1918

Conjunctivitis (acute, non atopic), including avohilmo

3114

14012

1.36

51.04

1.6

1.7

298.75

305.58

mu/l

0.41

2840

12689

Caries of dentine

623

3165

1.95

50.50

1.9

1.7

356.16

294.74

mu/l

2.45

569

2888

Disturbance of activity and attention

997

6000

1.72

49.80

1.6

311.91

305.46

mu/l

0.22

882

5411

Other endocrine disorders

273

1020

2.78

48.12

2.9

1.4

365.67

307.36

mu/l

1.48

246

915

Hyperkinetic disorders

1033

6321

1.69

48.03

1.6

319.37

310.73

mu/l

0.28

914

5692

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

391

1804

2.33

47.78

2.0

1.7

495.33

276.10

mu/l

8.23

332

1659

Mental disorders, not otherwise specified

439

2118

2.21

47.75

1.8

1.6

444.18

266.32

mu/l

8.02

402

1911

Dermatitis and eczema

3477

15732

1.32

47.69

1.7

301.15

304.70

mu/l

0.20

3150

14263

Any gastric operation

2988

11170

1.36

47.61

1.7

1.6

301.30

308.39

mu/l

0.43

2706

10084

GASTRO-related operations

2988

11170

1.36

47.61

1.7

1.6

301.30

308.39

mu/l

0.43

2706

10084

Asthma-related infections

1821

12412

1.45

47.40

1.7

321.44

305.03

mu/l

0.98

1667

11215

Asthma, hospital admission 2, infections

1821

12412

1.45

47.40

1.7

321.44

305.03

mu/l

0.98

1667

11215

1557

10505

1.50

47.36

1.7

318.04

304.55

mu/l

0.68

1420

9488

Other eating disorders

442

2176

2.26

47.32

1.8

1.7

364.72

318.37

mu/l

1.09

382

1969

Soft tissue disorders

3500

13723

1.32

46.33

1.7

291.31

308.67

mu/l

2.07

3185

12402

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1454

9429

1.51

46.17

1.8

1.7

291.10

308.14

mu/l

1.02

1332

8556

Convulsions, not elsewhere classified

819

4775

1.74

45.96

1.8

1.7

376.76

298.58

mu/l

4.43

725

4360

Mental and behavioural disorders due to sedatives or hypnotics

311

1319

2.51

45.93

2.1

1.7

439.81

279.85

mu/l

6.04

265

1217

Migraine without aura

1093

6984

1.63

45.88

1.6

339.15

308.46

mu/l

1.30

998

6262

Mouth breathing

966

5937

1.66

45.83

1.8

1.7

274.31

288.07

mu/l

0.75

883

5457

Other sleep disorders

386

1784

2.25

45.75

1.7

325.77

297.23

mu/l

0.66

352

1605

Adenomyosis (Endometriosis of uterus)

325

1390

2.41

45.70

1.6

1.8

284.07

365.15

mu/l

5.96

290

1215

Abnormalities of breathing

3043

13135

1.34

45.60

1.7

312.10

305.10

mu/l

0.42

2756

11874

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2152

12072

1.41

45.51

1.6

298.07

316.94

mu/l

1.33

1939

10805

Dorsopathies

3504

13621

1.32

45.39

1.6

1.7

293.36

312.25

mu/l

1.93

3194

12316

Oxycodone

677

3212

1.83

45.17

1.7

1.9

342.34

294.76

mu/l

2.28

638

2945

Extrapyramidal and movement disorders

761

4422

1.75

44.70

1.9

1.8

312.10

295.29

mu/l

0.65

695

4020

Diarrhoea and gastroenteritis of presumed infectious origin

2343

15441

1.37

43.73

1.8

1.7

321.06

301.56

mu/l

1.54

2130

13985

Disorders of skin appendages

1870

13300

1.43

43.58

1.7

298.99

308.15

mu/l

0.62

1718

12002

Other extrapyramidal and movement disorders in other diseases

573

3095

1.89

43.34

1.8

1.7

288.78

300.00

mu/l

0.41

524

2813

Wide developmental disorders, excluding more controls

233

872

2.89

43.27

2.0

1.5

392.67

265.37

mu/l

4.73

200

792

Persons encountering health services for specific procedures, not carried out

379

1797

2.22

42.64

2.0

1.7

428.49

289.44

mu/l

4.29

318

1634

Nausea and vomiting

793

4610

1.71

42.60

1.9

1.7

358.82

312.53

mu/l

1.89

701

4176

Benign neoplasm of meninges

228

855

2.76

42.56

2.9

1.7

391.99

297.07

mu/l

2.57

219

776

Injuries to the ankle and foot

2594

16669

1.35

42.56

1.6

1.7

301.99

305.59

mu/l

0.19

2353

15100

Substance abuse

1679

10958

1.44

42.34

1.8

1.7

399.53

285.20

mu/l

14.10

1469

10030

Monoamine oxidase A inhibitors

275

1133

2.50

42.26

1.9

1.8

338.10

285.26

mu/l

2.13

250

1050

Implicit viral Sepsis

510

2683

1.95

41.88

2.0

1.7

346.95

292.37

mu/l

2.27

461

2457

Other diseases of hard tissues of teeth

1207

4023

1.57

41.85

1.7

1.8

289.25

299.94

mu/l

0.53

1111

3680

Galactorrhea

112

290

4.96

41.61

2.3

1.7

558.52

313.11

mu/l

0.45

103

261

Viral Sepsis

510

2692

1.94

41.46

2.0

1.7

346.95

293.46

mu/l

2.19

461

2466

Chronic diseases of tonsils and adenoids

2638

12512

1.35

41.38

1.6

1.7

285.43

315.39

mu/l

3.46

2410

11297

Abnormalities of heart beat

1036

6440

1.59

41.35

1.7

314.07

307.67

mu/l

0.18

923

5825

Mental and behavioural disorders due to psychoactive substance use

1733

11259

1.43

41.33

1.8

1.7

396.27

286.12

mu/l

13.88

1517

10303

Anorexia (incl.atypical)

412

2066

2.17

41.15

1.8

1.7

333.51

306.54

mu/l

0.64

364

1865

Benign neoplasm: Cerebral meninges

212

780

2.81

41.12

2.8

1.7

406.01

299.10

mu/l

2.84

204

710

Dissociative [conversion] disorders

261

1088

2.65

41.09

1.9

1.6

462.97

290.98

mu/l

4.85

220

972

Persistent delusional disorders

226

864

2.73

40.94

2.1

1.6

619.03

266.32

mu/l

8.74

198

793

Other disorders of breast

528

2855

1.93

40.71

1.7

331.22

311.54

mu/l

0.14

493

2541

Somatoform disorder

554

3034

1.89

40.67

1.7

1.6

322.09

281.15

mu/l

1.52

492

2745

Psychotic depression

232

904

2.70

40.66

1.8

1.6

496.85

263.96

mu/l

1.05

205

830

Other abnormal uterine and vaginal bleeding

545

2090

1.91

40.28

1.6

1.7

306.89

379.21

mu/l

2.80

489

1811

Tramadol

2154

9465

1.38

40.04

1.7

305.82

299.32

mu/l

0.31

1969

8599

Metabolic disorders

2412

10783

1.36

39.46

2.0

1.7

318.56

297.74

mu/l

1.43

2219

9806

Oedema, not elsewhere classified

704

4054

1.72

39.16

1.8

1.7

326.20

292.75

mu/l

1.70

631

3703

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

337

1590

2.26

38.89

1.8

1.6

453.17

295.79

mu/l

6.36

307

1440

Other maternal disorders predominantly related to pregnancy

2149

9922

1.38

38.74

1.6

1.7

289.07

332.50

mu/l

5.76

1901

8883

Low back pain

2569

13137

1.34

38.71

1.7

300.13

310.67

mu/l

0.64

2339

11860

Inflammatory diseases of female pelvic organs

2380

12232

1.35

38.65

1.6

311.02

321.77

mu/l

0.61

2146

10899

Autoimmune diseases

3576

14274

1.28

38.47

1.7

312.59

303.28

mu/l

0.66

3202

12992

Other symptoms and signs involving cognitive functions and awareness

837

4583

1.64

38.15

2.0

1.7

373.69

285.15

mu/l

5.76

752

4191

Dysphagia

502

2714

1.88

37.75

1.9

1.8

324.92

293.19

mu/l

0.77

455

2478

Tonsillectomy and adenotomy

2607

13880

1.33

37.59

1.6

1.7

284.46

310.74

mu/l

3.41

2370

12520

Conjunctivitis

2604

16043

1.32

37.56

1.7

310.11

308.15

mu/l

0.09

2382

14485

Fibromyalgia

377

1871

2.11

37.51

1.5

1.7

281.78

309.57

mu/l

1.20

334

1677

Pure hypercholesterolaemia

1317

5664

1.49

37.42

1.9

1.7

298.75

282.41

mu/l

0.80

1232

5197

Social phobias

510

2822

1.91

37.31

1.8

1.6

338.92

279.80

mu/l

2.85

439

2557

Covid-19 confirmed case

968

6257

1.57

37.26

1.8

1.7

344.75

302.84

mu/l

2.41

851

5665

Disorders of conjunctiva

2747

16419

1.31

37.04

1.7

310.44

307.23

mu/l

0.15

2517

14833

Certain infectious and parasitic diseases

3116

12126

1.30

36.89

1.7

311.50

301.52

mu/l

0.69

2824

10969

Disorders of lipoprotein metabolism and other lipidaemias

1569

6695

1.44

36.77

1.9

1.7

305.44

286.28

mu/l

0.98

1446

6143

Symptoms and signs concerning food and fluid intake

304

1395

2.25

36.40

2.2

1.7

343.37

297.21

mu/l

1.25

287

1273

Temporomandibular joint disorders, including avohilmo

1922

13810

1.38

35.94

1.6

288.27

313.81

mu/l

2.90

1743

12389

Migraine with aura

1165

7941

1.51

35.87

1.7

1.6

313.99

308.49

mu/l

0.17

1061

7134

Other pulmonary diagnosis

2400

9049

1.34

35.81

1.7

300.27

304.46

mu/l

0.20

2166

8197

Manic episode

152

517

3.20

35.09

2.2

1.7

553.94

274.63

mu/l

6.18

135

466

Polyuria

456

2453

1.90

34.98

1.9

1.8

302.99

290.90

mu/l

0.23

427

2246

COPD/asthma/ILD related infections

3087

12081

1.29

34.97

1.7

309.66

303.02

mu/l

0.42

2764

10943

COPD/asthma related infections

3087

12081

1.29

34.97

1.7

309.66

303.02

mu/l

0.42

2764

10943

Diseases of the skin and subcutaneous tissue

3021

11828

1.29

34.57

1.7

300.99

304.91

mu/l

0.20

2740

10687

Other disorders of lacrimal gland

898

5818

1.57

34.45

1.8

1.7

291.29

307.39

mu/l

0.95

801

5250

ILD differential diagnosis

2379

9011

1.34

34.42

1.7

302.52

304.51

mu/l

0.09

2147

8161

Other/unspecified dorsalgia

1051

6961

1.52

34.24

1.7

296.18

308.50

mu/l

0.56

954

6300

Emotional disorders and disorders of social functioning with onset specific to childhood

409

2145

2.04

34.22

2.0

1.6

425.11

305.31

mu/l

4.11

350

1935

Diseases of oral cavity, salivary glands and jaws

1169

4024

1.51

34.21

1.7

1.8

297.43

300.08

mu/l

0.09

1076

3681

COPD differential diagnosis

2379

9020

1.34

34.21

1.7

302.51

304.43

mu/l

0.08

2147

8170

Excluding asthma or asthma-COPD overlap

2385

9049

1.34

34.11

1.7

301.94

304.46

mu/l

0.11

2151

8197

Candidiasis, including avohilmo

1077

7289

1.51

34.10

1.7

1.6

335.96

311.16

mu/l

1.03

957

6538

Gestational diabetes (for exclusion)

2059

10673

1.36

33.88

1.5

1.6

290.70

319.22

mu/l

1.04

1799

9565

Constipation

2127

10823

1.34

33.79

1.8

1.7

348.40

300.59

mu/l

4.14

1913

9855

Lower back pain or/and sciatica

3280

16225

1.27

33.20

1.7

298.35

305.32

mu/l

0.45

2982

14682

Acne, including avohilmo

1531

9003

1.43

33.14

1.7

1.6

326.65

311.45

mu/l

0.77

1372

8044

Certain infectious and parasitic diseases, including avohilmo

2091

7820

1.35

32.95

1.7

304.51

303.01

mu/l

0.06

1891

7055

Symptoms and signs involving the skin and subcutaneous tissue

2034

14502

1.34

32.92

1.7

298.72

307.57

mu/l

0.51

1871

13112

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2010

11132

1.35

32.89

1.6

299.75

321.01

mu/l

1.46

1813

9915

3279

13184

1.27

32.86

1.7

298.94

305.96

mu/l

0.50

2958

11934

Use of biperiden

167

617

2.85

32.61

2.1

1.7

685.34

295.10

mu/l

7.71

152

572

Disturbances of skin sensation

989

6648

1.52

32.45

1.7

297.09

308.06

mu/l

0.39

907

5971

Gingivitis and periodontal diseases

2630

10505

1.30

32.35

1.7

302.84

303.79

mu/l

0.04

2375

9577

Malignant melanoma

279

1297

2.20

32.28

1.8

310.40

297.55

mu/l

0.15

259

1194

Asthma (diagnoses ohter than nonallergic)

2640

16679

1.29

32.15

1.7

314.80

306.16

mu/l

0.53

2419

15083

Excessive attrition of teeth

2058

15511

1.33

31.86

1.7

307.61

307.14

mu/l

0.02

1856

14028

Dental operations

1220

4293

1.48

31.80

1.7

1.8

296.92

298.31

mu/l

0.04

1119

3949

Myalgia

808

5226

1.58

31.66

1.7

308.25

315.05

mu/l

0.18

720

4708

Type 2 diabetes, definitions combined

2532

11405

1.30

31.64

1.8

1.7

337.68

293.96

mu/l

2.40

2290

10372

Migraine without aura and triptan purchases

899

5991

1.56

31.62

1.7

1.6

336.95

317.14

mu/l

0.59

821

5329

Type 2 diabetes, definitions combined, including avohilmo

2589

11624

1.30

31.58

1.8

1.7

338.62

294.07

mu/l

2.56

2341

10566

Malignant melanoma, including Hilmo

305

1480

2.10

31.55

1.9

1.8

317.84

299.69

mu/l

0.24

282

1349

Malignant melanoma of skin, including Hilmo

266

1225

2.22

31.55

1.9

1.8

314.70

293.92

mu/l

0.24

249

1119

Disorders of lacrimal system

1048

7022

1.49

31.51

1.8

1.7

287.05

309.07

mu/l

1.81

943

6342

Mental and behavioural disorders due to opioids

226

994

2.47

31.48

1.9

1.7

484.69

279.14

mu/l

4.73

191

916

Emotional disorders starting during childhood or adolescence

384

2056

2.02

31.42

2.1

1.6

438.62

305.50

mu/l

4.44

328

1861

Type 2 diabetes, strict (exclude DM1)

2535

11432

1.30

31.41

1.8

1.7

337.39

294.21

mu/l

2.35

2292

10397

Chronic rhinitis, nasopharyngitis and pharyngitis

974

6567

1.51

31.17

1.8

1.7

289.08

314.54

mu/l

1.39

895

5935

Asthma-related pneumonia

786

5036

1.58

31.10

1.8

1.7

345.72

294.77

mu/l

2.76

724

4569

Asthma, unspecified (mode)

1510

7884

1.40

31.07

1.7

311.25

307.24

mu/l

0.14

1374

7134

Lung cancer and mesothelioma

238

879

2.33

31.03

1.6

2.0

315.55

280.91

mu/l

1.20

233

813

Restless leg syndrome

386

2054

1.93

31.02

1.8

1.7

292.15

298.83

mu/l

0.16

351

1859

Injuries to the wrist and hand

3132

16598

1.26

30.93

1.7

308.52

305.34

mu/l

0.16

2833

15047

First line medication for Crohn's disease

3503

15209

1.25

30.64

1.9

1.6

296.17

304.47

mu/l

0.68

3249

13689

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1376

9849

1.42

30.61

1.6

348.85

309.10

mu/l

2.44

1221

8851

Asthma-related pneumonia or sepsis

787

5065

1.57

30.54

1.8

1.7

345.41

294.73

mu/l

2.74

725

4592

Asthma, hospital admissions 3, pneumonia

787

5065

1.57

30.54

1.8

1.7

345.41

294.73

mu/l

2.74

725

4592

Cardiovascular diseases

2915

12261

1.28

30.50

1.7

1.6

301.61

309.62

mu/l

0.53

2643

11057

Supervision of high-risk pregnancy

952

3816

1.55

30.45

1.6

1.8

298.74

368.79

mu/l

6.56

813

3361

Diseases of the eye and adnexa

2984

11856

1.28

30.33

1.7

1.6

303.44

301.54

mu/l

0.10

2679

10730

Asthma, unspecified (mode), excluding more controls

1502

7802

1.39

30.28

1.7

309.97

307.03

mu/l

0.10

1366

7060

Ovarian hyperstimulation (induction)

153

580

3.08

30.28

1.4

1.7

272.84

290.19

mu/l

0.42

139

522

Autism spe, excluding more controls

172

681

2.78

30.17

2.0

1.5

369.40

262.46

mu/l

3.10

142

608

Other symptoms and signs involving general sensations and perceptions

144

514

2.96

30.09

2.4

1.7

631.17

283.51

mu/l

6.75

132

459

Hypothyroidism, drug reimbursement

477

1878

1.82

29.84

1.7

1.5

280.90

260.06

mu/l

1.09

430

1713

Transport accidents

1602

9863

1.37

29.58

1.6

1.7

300.31

299.05

mu/l

0.05

1470

8919

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2298

16324

1.30

29.51

1.6

1.7

315.42

305.09

mu/l

0.63

2089

14758

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1432

10240

1.39

29.27

1.7

304.58

303.05

mu/l

0.05

1304

9268

Undetermined asthma, excluding more controls

368

1963

1.92

29.23

1.8

1.7

303.73

298.34

mu/l

0.11

330

1789

Other diseases of upper respiratory tract

3090

12869

1.26

29.20

1.7

288.82

314.80

mu/l

3.34

2814

11628

Urinary track infection

2304

8911

1.31

29.19

1.6

327.11

320.37

mu/l

0.18

2050

7967

Chronic sinusitis

1186

8391

1.43

29.13

1.7

268.38

315.54

mu/l

5.58

1077

7585

Asthma, hospital admissions , main diagnosis only

2472

16922

1.28

29.02

1.7

314.68

305.78

mu/l

0.54

2270

15298

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1080

7462

1.45

28.88

1.7

1.8

389.83

274.01

mu/l

9.56

943

6858

Undetermined asthma

368

1972

1.91

28.83

1.8

1.7

303.73

298.30

mu/l

0.11

330

1796

Pain in limb

2634

13215

1.28

28.82

1.7

309.03

308.12

mu/l

0.04

2399

11931

Alcohol use disorder, ICD-based

1016

7012

1.47

28.76

1.7

1.8

393.51

275.47

mu/l

9.23

885

6446

Postprocedural endocrine and metabolic disorders, not elsewhere classified

396

2183

1.87

28.65

2.4

1.7

298.01

295.79

mu/l

0.05

367

1958

Other diseases of intestines

3468

15704

1.24

28.65

1.7

297.07

305.88

mu/l

0.67

3175

14192

Type 2 diabetes

2769

12710

1.27

28.65

1.8

1.7

335.26

295.25

mu/l

2.35

2500

11548

Epilepsy

757

4909

1.56

28.58

1.8

1.7

353.60

299.07

mu/l

3.29

682

4468

Sciatica+with lumbago

1357

8720

1.39

28.31

1.7

305.80

309.53

mu/l

0.12

1229

7903

Abnormal involuntary movements

367

1981

1.91

28.28

1.9

1.7

320.82

291.74

mu/l

0.88

338

1802

Hypertension, essential

1929

8262

1.33

28.15

1.8

1.7

295.25

296.33

mu/l

0.04

1768

7517

Other and unspecified effects of external causes

1035

7223

1.47

28.14

1.8

1.6

340.09

306.95

mu/l

1.74

932

6533

Any operation in hilmo

139

230

3.18

27.94

1.6

1.2

311.61

270.56

mu/l

0.64

132

211

Disorders of thyroid, IBD co-morbidities

685

2976

1.61

27.52

1.7

1.6

298.74

318.74

mu/l

0.62

612

2655

178

756

2.65

27.51

1.6

294.60

279.14

mu/l

0.22

151

667

Primary adrenocortical insufficiency

174

4.70

27.47

2.4

1.6

342.06

322.82

mu/l

0.22

156

Malignant melanoma of skin

226

1035

2.23

27.30

1.9

1.8

308.41

292.12

mu/l

0.16

212

949

Coxibs

841

2903

1.54

27.02

1.6

1.8

292.78

353.94

mu/l

3.58

760

2594

Provisional assignment of new diseases of uncertain etiology

1627

12187

1.34

26.73

1.7

323.54

304.00

mu/l

1.28

1452

11011

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1308

9526

1.38

26.71

1.7

303.76

299.74

mu/l

0.13

1196

8626

Deviated nasal septum

706

4590

1.56

26.60

1.7

1.8

255.96

286.38

mu/l

2.02

645

4209

Other metabolic disorders

411

2343

1.81

26.58

2.4

1.7

296.56

293.23

mu/l

0.08

382

2108

Codes for special purposes

1627

12198

1.34

26.55

1.7

323.54

304.04

mu/l

1.27

1452

11020

Abnormal findings on examination of blood, without diagnosis

906

5605

1.48

26.41

2.0

1.7

321.51

290.22

mu/l

1.14

837

5123

Other joint disorders

3200

13562

1.24

26.38

1.6

1.7

283.84

312.88

mu/l

5.22

2917

12259

Other general symptoms and signs

231

1084

2.22

26.30

2.0

1.7

309.06

297.94

mu/l

0.22

196

991

Syncope and collapse

1013

5906

1.45

26.11

1.9

1.7

339.69

295.44

mu/l

2.30

898

5383

Functional dyspepsia

702

4592

1.56

26.05

1.7

284.35

301.48

mu/l

0.77

634

4151

Subjective visual disturbances

691

4510

1.56

25.98

1.8

1.6

309.86

301.53

mu/l

0.24

628

4067

Mental and behavioural disorders due to alcohol

1312

9165

1.38

25.97

1.7

380.43

281.33

mu/l

9.04

1155

8408

Acetic acid derivatives and related substances

813

2769

1.54

25.88

1.6

1.8

299.19

355.46

mu/l

2.53

732

2471

Other (not insulin) diabetes medications

2543

11868

1.27

25.76

1.8

1.7

334.06

295.18

mu/l

1.95

2296

10797

Chronic lower respiratory diseases

3689

16049

1.22

25.74

1.6

1.7

311.92

303.76

mu/l

0.55

3371

14526

Pain in throat and chest

2591

12239

1.26

25.64

1.8

1.7

315.50

304.28

mu/l

0.65

2359

11083

Diabetes mellitus in pregnancy

1809

8839

1.33

25.63

1.5

1.6

290.58

327.91

mu/l

1.31

1584

7909

Rheumatism, unspecified

278

1415

2.01

25.43

1.7

1.8

323.01

324.67

mu/l

0.02

246

1283

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1875

13927

1.31

25.39

1.7

308.54

311.66

mu/l

0.12

1715

12535

Primary ovarian failure

130

493

2.96

25.26

1.5

1.3

248.27

290.05

mu/l

1.60

124

439

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1205

7592

1.39

25.26

1.8

309.73

297.11

mu/l

0.56

1112

6934

Hypertensive diseases (excluding secondary)

1651

7249

1.34

25.24

1.8

1.7

296.82

296.16

mu/l

0.02

1501

6578

Malignant neoplasm of respiratory system and intrathoracic organs

251

1008

2.09

25.17

1.6

1.9

311.57

289.54

mu/l

0.69

244

921

Gastrointestinal diseases

2309

9115

1.28

25.01

1.7

1.6

307.78

308.41

mu/l

0.03

2093

8192

Mental and behavioural disorders due to cannabinoids

187

840

2.43

24.99

2.1

1.6

530.19

279.29

mu/l

4.83

156

770

Speech and linguistic disorders, excluding more controls

385

2063

1.83

24.96

1.9

1.6

390.39

282.58

mu/l

4.47

351

1873

Migraine with aura and triptan purchases

838

5781

1.50

24.91

1.6

325.97

317.52

mu/l

0.21

759

5130

Diseases of the musculoskeletal system and connective tissue

2140

8382

1.30

24.81

1.6

1.7

294.37

320.62

mu/l

2.51

1942

7532

Hypotension

232

1113

2.11

24.75

2.0

1.7

344.64

298.09

mu/l

1.00

214

1023

Wide developmental disorders

233

1144

2.21

24.71

2.0

1.7

392.67

303.68

mu/l

2.52

200

1035

Outcome of delivery

835

3486

1.52

24.69

1.4

1.7

291.88

366.23

mu/l

6.13

766

3066

Bulimia nervosa (incl. atypical)

276

1459

2.09

24.54

1.6

351.71

299.76

mu/l

1.10

233

1305

Other disorders starting during childhood or adolecense, excluding more controls

289

1459

2.01

24.50

1.8

1.6

355.00

293.43

mu/l

1.40

253

1305

Postmenopausal bleeding

310

825

1.99

24.49

1.7

1.9

334.11

445.50

mu/l

1.73

269

736

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

280

1174

1.98

24.35

1.6

1.9

315.32

295.36

mu/l

0.60

271

1079

Type 2 diabetes, wide definition

1442

6760

1.36

24.35

1.9

1.8

353.26

282.41

mu/l

2.37

1309

6206

Symptoms and signs involving cognition, perception, emotional state and behaviour

2676

14438

1.25

24.25

1.9

1.7

346.79

297.26

mu/l

6.42

2436

13083

Brain meningioma

113

397

2.95

24.17

2.8

1.8

414.86

310.93

mu/l

1.87

108

355

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2709

17109

1.24

24.10

1.7

297.12

306.98

mu/l

0.69

2480

15489

Alcohol use disorder, Swedish definition

1315

8865

1.36

24.06

1.7

380.15

277.32

mu/l

9.83

1163

8120

Dental caries, including avohilmo

1599

6166

1.34

23.89

1.7

294.48

295.97

mu/l

0.06

1444

5665

Malignant neoplasm of bronchus and lung, including Hilmo

231

925

2.11

23.72

1.5

2.0

311.92

290.37

mu/l

0.61

226

847

Pervasive developmental disorders excl. Autism + Asperger

294

3.51

23.67

2.0

1.7

436.60

308.40

mu/l

2.13

273

Hypoparathyroidism

307

3.24

23.64

2.8

1.3

348.73

290.89

mu/l

0.85

273

Biguanides

2365

11381

1.26

23.62

1.8

1.7

327.55

296.54

mu/l

1.27

2139

10350

Primary amenorrhea

305

3.88

23.59

1.7

1.5

274.02

306.29

mu/l

0.46

270

Sexual dysfunction

296

3.39

23.55

1.6

1.7

246.05

290.14

mu/l

0.85

275

Complications of medical and surgical care

1798

12554

1.30

23.53

1.7

311.73

305.68

mu/l

0.24

1636

11387

Implicit bacterial Sepsis

620

3433

1.56

23.50

1.9

1.8

358.64

280.12

mu/l

3.23

556

3166

Disorders of psychological development

653

4016

1.57

23.46

1.9

1.7

401.91

312.07

mu/l

4.92

576

3632

Spondylosis

902

4903

1.45

23.45

1.7

1.8

284.88

305.80

mu/l

1.23

814

4500

Assault

546

3477

1.62

23.45

1.8

1.7

354.37

284.39

mu/l

2.63

488

3174

Concussion

1594

9446

1.32

23.32

1.7

1.6

333.75

304.42

mu/l

0.76

1417

8551

Viral hepatitis, including avohilmo

302

1643

1.92

23.27

1.8

1.7

393.83

277.66

mu/l

3.66

256

1510

Brain meningioma, including Hilmo

114

411

2.87

23.25

2.8

1.8

412.47

310.66

mu/l

1.84

109

369

Inflammatory diseases of prostate (prostatitis)

210

996

2.15

23.25

1.8

1.9

261.69

258.68

mu/l

0.05

203

944

Problems related to lifestyle

395

2323

1.76

23.15

2.0

1.6

457.55

274.11

mu/l

7.41

342

2095

Allergic conjunctivitis

1942

14731

1.28

23.13

1.7

307.33

311.95

mu/l

0.19

1777

13267

Diseases of pulp and periapical tissues, including avohilmo

3144

13372

1.23

22.99

1.8

1.6

317.77

300.74

mu/l

1.63

2800

12204

Other CVD

265

1371

1.96

22.94

1.9

1.8

342.23

299.67

mu/l

1.00

244

1269

Hyperhidrosis

168

745

2.42

22.88

1.6

260.57

295.08

mu/l

1.56

154

678

Thyroiditis, ILD-related definition

410

2447

1.73

22.78

2.1

1.7

321.95

308.91

mu/l

0.29

375

2204

Mental and behavioural disorders due to use of other stimulants, including caffeine

176

803

2.39

22.74

2.2

1.6

540.90

284.40

mu/l

4.73

147

734

Acute sinusitis

1761

12499

1.30

22.53

1.7

1.6

290.04

305.20

mu/l

1.16

1608

11297

Implicit bacterial Sepsis, including avohilmo

713

3981

1.50

22.50

1.9

1.8

348.80

278.41

mu/l

3.29

640

3664

Other CVD (FINNGEN)

212

767

2.15

22.29

1.9

1.7

348.24

289.21

mu/l

1.24

197

695

Nonalcoholic fatty liver disease

281

1509

1.92

22.22

1.8

1.7

284.23

293.69

mu/l

0.24

258

1377

Viral hepatitis

282

1525

1.93

22.17

1.7

389.96

279.84

mu/l

3.21

237

1404

Diseases of pulp and periapical tissues and dental caries

1437

5536

1.34

21.94

1.7

296.62

296.47

mu/l

0.01

1300

5094

Caries of dentine, including avohilmo

1849

7353

1.30

21.92

1.7

295.85

297.49

mu/l

0.08

1667

6753

Hypokalaemia

231

1162

2.03

21.89

2.1

1.7

344.67

290.64

mu/l

1.34

214

1058

Sequelae of external causes of morbidity and mortality

546

3512

1.58

21.88

1.8

1.7

357.55

296.55

mu/l

2.46

499

3186

Sleep disorders, other/unspecified

188

897

2.24

21.45

1.9

1.7

352.13

307.56

mu/l

0.55

158

815

Symptoms and signs involving the urinary system

1614

9423

1.30

21.22

1.8

1.7

317.48

298.96

mu/l

1.06

1493

8571

Persons with potential health hazards related to communicable diseases

1676

13043

1.30

21.21

1.7

1.6

295.13

309.23

mu/l

1.07

1425

11824

Diplopia

308

1727

1.83

21.07

1.9

1.6

394.56

295.98

mu/l

0.50

280

1585

Cervicobrachial syndrome

545

3545

1.56

20.87

1.7

291.85

311.47

mu/l

0.69

505

3212

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

324

1785

1.78

20.76

1.6

1.8

327.61

293.94

mu/l

1.31

314

1630

Diseases of the respiratory system

1872

7367

1.29

20.71

1.7

300.72

309.37

mu/l

0.45

1684

6661

Intracranial injury

1602

11638

1.30

20.69

1.8

1.7

340.96

300.27

mu/l

1.22

1411

10589

Haemorrhage in early pregnancy

1073

7720

1.38

20.69

1.5

1.6

286.65

326.97

mu/l

3.39

939

6908

Diaphragmatic hernia

529

3419

1.56

20.60

1.8

286.29

294.58

mu/l

0.18

490

3115

Adverse effects, not elsewhere classified

701

4836

1.48

20.51

1.8

1.7

334.01

312.82

mu/l

0.69

637

4364

Infections of the skin and subcutaneous tissue

1750

13606

1.28

20.49

1.8

1.7

318.33

299.47

mu/l

1.20

1597

12351

Symptoms and signs involving emotional state

144

628

2.45

20.40

1.8

1.7

408.80

289.97

mu/l

2.70

135

564

Endometriosis of rectovaginal septum and vagina

189

911

2.14

20.35

1.6

1.7

287.50

384.75

mu/l

3.76

173

793

Other viral hepatitis, including avohilmo

276

1527

1.89

20.30

1.8

1.7

410.76

275.67

mu/l

4.13

234

1405

Cervicalgia

485

3096

1.59

20.19

1.6

1.7

308.17

309.59

mu/l

0.02

450

2800

Hypertrophy of breast in women and men

576

3832

1.54

20.08

1.7

304.49

308.18

mu/l

0.09

525

3435

Follow-up examination after treatment for conditions other than malignant neoplasms

1216

6068

1.35

20.04

1.7

1.6

299.70

291.93

mu/l

0.34

1117

5385

Implicit Sepsis

1634

9402

1.29

20.00

1.9

1.7

356.13

295.20

mu/l

5.34

1468

8589

Infections with a predominantly sexual mode of transmission, including avohilmo

1864

13643

1.27

19.99

1.6

305.87

308.01

mu/l

0.09

1676

12278

Isolated growth hormone deficiency

139

4.66

19.97

3.4

1.5

302.22

337.06

mu/l

0.42

131

1437

9904

1.31

19.96

1.7

376.27

283.51

mu/l

8.94

1271

9067

Cluster headache, wide

153

692

2.33

19.72

2.3

1.6

281.54

304.84

mu/l

0.40

143

625

1527

10354

1.29

19.57

1.7

375.77

284.54

mu/l

9.23

1354

9470

Hypertension

1965

8833

1.26

19.57

1.8

1.7

295.68

296.30

mu/l

0.03

1796

8035

Other and unspecified iron deficiency

777

5479

1.43

19.55

1.8

1.7

322.13

305.50

mu/l

0.60

699

4961

Diseases of the ear and mastoid process

3544

14998

1.19

19.49

1.7

302.34

305.34

mu/l

0.16

3202

13596

Pain in thoracic spine

437

2752

1.62

19.45

1.7

313.55

310.24

mu/l

0.05

406

2482

Hypertensive diseases

1965

8846

1.26

19.36

1.8

1.7

295.77

296.38

mu/l

0.02

1795

8048

Chronic viral hepatitis

231

1229

1.98

19.35

1.8

1.7

408.81

274.46

mu/l

3.42

190

1128

Other viral hepatitis

258

1421

1.90

19.29

1.8

1.7

407.05

276.98

mu/l

3.73

217

1307

Implicit fungal Sepsis, including avohilmo

169

799

2.18

19.16

1.9

1.6

351.44

291.15

mu/l

0.77

144

728

External causes of morbidity and mortality

2097

8449

1.26

19.11

1.7

312.35

295.09

mu/l

1.25

1889

7651

Falls/tendency to fall

3404

14378

1.19

19.09

1.7

303.16

303.27

mu/l

0.01

3078

13023

Arthropathies

3199

13572

1.20

18.98

1.6

1.7

286.50

312.82

mu/l

4.22

2921

12269

Cough

970

6659

1.37

18.95

1.8

1.7

319.45

310.42

mu/l

0.28

899

6035

Acute bronchitis

989

7168

1.37

18.92

1.7

311.36

303.68

mu/l

0.29

879

6520

Cluster headache, strict

149

680

2.31

18.86

2.4

1.6

283.59

305.22

mu/l

0.35

139

615

Alcohol dependence

537

3558

1.53

18.85

1.8

396.47

271.73

mu/l

6.59

474

3305

Diseases of middle ear and mastoid

2190

14609

1.24

18.84

1.7

1.6

313.27

302.57

mu/l

0.64

1954

13215

Iron deficiency anaemia

915

6556

1.38

18.80

1.8

1.7

326.39

303.05

mu/l

1.07

816

5931

Symptoms and signs involving speech and voice

685

4771

1.45

18.68

1.7

306.16

302.93

mu/l

0.09

629

4325

Sequelae with surgical and medical care as external cause

399

2480

1.64

18.61

1.8

1.7

368.05

294.08

mu/l

2.30

361

2248

Inflammatory disease of uterus

616

4241

1.50

18.58

1.6

292.18

312.53

mu/l

0.98

551

3754

Ectopic pregnancy

544

3647

1.53

18.43

1.6

1.7

286.95

324.54

mu/l

1.84

492

3264

Hyperplasia of prostate

468

1663

1.60

18.32

1.7

1.9

262.49

250.82

mu/l

0.21

441

1577

Erosion of teeth , including avohilmo

1016

7613

1.36

18.25

1.7

288.58

306.17

mu/l

0.99

922

6878

Thyrotoxicosis, other and/or unspecified

512

3395

1.54

18.08

1.6

292.30

296.02

mu/l

0.10

454

3066

Dizziness and giddiness

1752

10882

1.26

18.06

1.9

1.7

328.95

297.70

mu/l

2.27

1598

9855

Voice disturbances

577

3918

1.49

18.05

1.7

298.24

305.81

mu/l

0.21

535

3536

Diabetes, varying definitions

2932

14261

1.20

17.87

1.7

333.36

297.17

mu/l

2.18

2641

12964

Malignant neoplasm of breast

350

3657

0.61

17.87

1.7

323.20

323.09

mu/l

0.00

326

3271

Infections, IBD-co-morbidities

383

1651

1.66

17.81

1.8

1.7

383.77

301.59

mu/l

1.55

354

1477

Viral and other specified intestinal infections, including avohilmo

1258

9376

1.31

17.77

1.8

1.6

318.84

305.50

mu/l

0.60

1149

8446

Complications of procedures, not elsewhere classified

2085

13709

1.23

17.73

1.7

304.77

301.93

mu/l

0.11

1889

12422

Diabetes mellitus

2957

14348

1.20

17.70

1.7

333.58

297.05

mu/l

2.24

2665

13043

Personal history of other diseases and conditions

553

3752

1.52

17.66

1.7

1.6

328.67

308.14

mu/l

0.64

482

3372

Malignant neoplasm of breast, HER2-negative

350

3646

0.61

17.63

1.7

323.24

322.02

mu/l

0.02

326

3260

Alcohol abuse, main dg, excluding more controls

384

2406

1.63

17.48

1.7

356.61

255.64

mu/l

4.25

329

2210

Fenamates

422

1815

1.61

17.43

1.8

319.12

358.48

mu/l

0.70

379

1617

Other disorders of optic [2nd] nerve and visual pathways

200

1046

1.99

17.41

2.2

1.6

349.85

302.13

mu/l

0.96

186

949

Other diseases of liver

401

2543

1.60

17.29

1.9

1.7

275.36

297.33

mu/l

1.00

370

2322

Malignant neoplasm of breast, HER2-negative, including Hilmo

378

3822

0.63

17.22

1.7

314.79

324.00

mu/l

0.16

352

3416

Disorders of mineral metabolism

184

934

2.02

17.22

2.0

1.7

309.95

295.28

mu/l

0.28

168

862

Malignant neoplasm of breast, including Hilmo

378

3821

0.63

17.21

1.7

314.79

324.04

mu/l

0.17

352

3415

Gastro-oesophageal reflux disease

1519

10139

1.27

17.17

1.8

1.7

290.02

301.73

mu/l

0.68

1387

9224

Osteoporosis

308

1672

1.71

17.11

2.2

1.8

326.07

315.61

mu/l

0.17

291

1531

Maternal care for other conditions predominantly related to pregnancy

1041

7723

1.35

17.11

1.5

1.6

313.10

327.20

mu/l

0.18

922

6914

Intentional self-harm by sharp object

165

825

2.18

17.07

2.5

1.5

660.94

298.28

mu/l

8.64

145

739

Brachial plexus disorders

324

1967

1.70

17.04

1.7

329.41

299.80

mu/l

0.54

293

1774

120

516

2.37

16.94

2.1

1.7

391.81

286.96

mu/l

1.38

463

Female genital prolapse

469

1680

1.57

16.88

1.6

1.8

300.37

388.84

mu/l

2.62

417

1471

Postpartum care and examination

772

3501

1.43

16.83

1.6

1.8

282.78

369.27

mu/l

9.08

655

3076

Disorders of ocular muscles, binocular movement, accommodation and refraction

1570

12453

1.26

16.77

1.8

1.7

328.36

308.58

mu/l

1.01

1419

11244

Nutritional anaemias

993

7126

1.34

16.71

1.8

1.7

327.36

308.51

mu/l

0.79

889

6439

Allergic asthma (mode), excluding more controls

889

6453

1.37

16.67

1.7

1.6

314.62

308.72

mu/l

0.17

824

5807

Previous suicide attempt

284

3.12

16.63

2.0

1.5

546.80

289.54

mu/l

3.12

257

Hyperlipidaemia, other/unspecified

445

2601

1.55

16.63

2.0

1.7

314.29

276.15

mu/l

0.87

402

2410

Allergic asthma (mode)

889

6457

1.37

16.62

1.7

1.6

314.62

309.46

mu/l

0.15

824

5809

Cervical disc disorders

596

4135

1.46

16.57

1.8

268.36

306.12

mu/l

2.54

551

3778

Autism

178

926

2.08

16.45

2.0

1.7

379.62

305.08

mu/l

1.54

146

829

Other specific joint derangements/joint disorders

2572

13419

1.20

16.43

1.6

1.7

277.61

312.86

mu/l

6.65

2341

12126

Other external causes of accidental injury

2436

10127

1.21

16.40

1.7

310.62

299.91

mu/l

0.63

2195

9158

Lumbar disc prolapse

1560

9207

1.26

16.40

1.6

1.7

282.51

306.97

mu/l

1.60

1428

8370

Agoraphobia

185

973

2.03

16.37

1.9

1.6

377.23

276.99

mu/l

2.23

167

878

Schizotypal disorder

107

455

2.53

16.20

2.1

1.6

593.35

253.01

mu/l

5.74

417

Intracranial trauma

1780

9728

1.25

16.20

1.7

1.6

332.89

303.74

mu/l

0.86

1581

8812

Bacterial infection, other or unspecified

913

5740

1.35

16.14

1.8

1.7

343.25

287.71

mu/l

3.93

840

5236

Other disorders of urethra and urinary system

1888

10700

1.24

16.14

1.7

321.35

312.30

mu/l

0.43

1700

9638

Benign thyroid growths and nodules

517

3255

1.49

16.10

1.9

1.6

340.48

304.45

mu/l

0.29

474

2946

Assault by bodily force

324

2003

1.68

16.04

1.8

1.7

370.44

286.11

mu/l

1.88

286

1841

Maternal care for known or suspected abnormality of pelvic organs

1230

6483

1.31

15.86

1.4

1.7

262.48

336.10

mu/l

12.56

1092

5779

Personal history of risk-factors, not elsewhere classified

330

2.85

15.84

2.0

1.6

528.51

301.81

mu/l

2.87

296

Other and unspecified visual disturbances

269

1581

1.74

15.83

1.9

1.6

280.42

293.08

mu/l

0.45

249

1432

Weight loss

232

1307

1.82

15.80

2.1

1.6

352.11

308.47

mu/l

0.77

215

1183

Other diseases of anus and rectum

548

3764

1.47

15.79

1.9

1.7

310.99

300.15

mu/l

0.31

503

3414

Implicit Sepsis, including avohilmo

1892

11036

1.23

15.79

1.8

1.7

353.72

293.73

mu/l

5.70

1700

10074

Injuries to the neck

779

5734

1.38

15.76

1.6

1.7

306.72

303.61

mu/l

0.08

708

5200

Other acute lower respiratory infections

1417

10733

1.27

15.75

1.6

1.7

312.20

303.65

mu/l

0.43

1268

9768

Haemorrhage from respiratory passages

543

3298

1.47

15.71

1.9

1.8

311.56

288.96

mu/l

0.84

498

3011

Bacterial Sepsis

736

4400

1.39

15.70

1.9

1.8

360.42

279.01

mu/l

4.13

657

4045

Hernia of abdominal wall, postoperative

348

2167

1.62

15.65

1.7

269.12

287.48

mu/l

0.74

322

1968

Anogenital herpesviral [herpes simplex] infection, including avohilmo

605

4301

1.46

15.65

1.7

1.6

296.54

307.80

mu/l

0.34

548

3839

Disorders of optic nerve and visual pathways

309

1898

1.68

15.56

2.3

1.7

333.74

294.69

mu/l

1.17

284

1715

Disorders of calcium metabolism

132

616

2.20

15.53

2.0

1.6

333.97

289.34

mu/l

0.85

119

572

Contact with and exposure to communicable diseases

1451

11618

1.27

15.27

1.7

1.6

294.59

309.14

mu/l

0.95

1213

10518

Other noninflammatory disorders of vagina

182

964

1.93

15.12

1.5

1.8

284.69

380.91

mu/l

4.76

161

842

Bacterial infection, other or unspecified, including avohilmo

1071

6756

1.31

15.04

1.8

1.7

331.05

290.68

mu/l

2.89

984

6164

Congenital malformations, deformations and chromosomal abnormalities

2033

16017

1.22

15.02

1.6

1.7

317.49

305.71

mu/l

0.69

1845

14481

Soft tissue disorders related to use, overuse and pressure

492

3359

1.48

14.98

1.7

1.8

297.12

298.70

mu/l

0.03

451

3058

Other and unspecified anaemias

603

4006

1.42

14.88

2.0

1.8

357.04

292.80

mu/l

3.21

558

3655

Accidents

2415

10127

1.20

14.88

1.7

315.08

299.91

mu/l

1.01

2182

9158

Invasive ventilation

164

844

2.00

14.88

1.9

1.6

463.87

291.75

mu/l

2.19

137

778

Abrasion of teeth

832

6230

1.35

14.84

1.8

1.7

293.58

300.93

mu/l

0.28

751

5628

Trochanteric bursitis

257

1516

1.72

14.78

1.8

341.13

315.86

mu/l

0.30

230

1380

Mycoses

677

4922

1.39

14.65

1.8

1.7

328.20

298.87

mu/l

1.08

614

4453

Anankastic personality disorder

180

971

1.96

14.65

1.9

1.6

352.20

290.05

mu/l

1.14

161

882

Use of pramipexole

334

2110

1.60

14.62

1.9

1.7

276.75

303.45

mu/l

0.77

300

1924

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

247

1452

1.75

14.62

1.9

1.7

376.52

295.47

mu/l

1.89

219

1311

Asthma and allergy

580

4072

1.44

14.61

1.7

1.6

326.54

314.39

mu/l

0.32

537

3667

Maternal care for known or suspected fetal abnormality and damage

896

5785

1.35

14.59

1.5

1.7

273.34

333.80

mu/l

5.98

814

5158

584

4196

1.45

14.52

1.5

1.6

310.29

297.48

mu/l

0.35

515

3725

Abnormal findings on diagnostic imaging of central nervous system

170

898

1.97

14.51

2.1

1.7

294.75

299.81

mu/l

0.07

164

813

Other anaemias

606

4039

1.41

14.45

2.0

1.8

356.86

294.23

mu/l

3.08

561

3683

Autism spe

172

926

2.01

14.45

2.0

1.7

369.40

305.43

mu/l

1.33

142

835

Injury, poisoning and certain other consequences of external causes

1726

7031

1.24

14.45

1.6

1.7

299.13

293.04

mu/l

0.33

1543

6369

Disorders of breast

1485

10564

1.25

14.35

1.6

329.25

318.52

mu/l

0.19

1343

9420

L02BG Aromatase inhibitors

409

2680

1.52

14.29

1.7

1.8

268.89

322.44

mu/l

2.27

388

2401

Diseases of the digestive system

867

6508

1.33

14.29

1.9

1.7

332.06

297.26

mu/l

1.39

793

5931

Asthma and allergy, excluding more controls

580

4092

1.43

14.25

1.7

1.6

326.54

315.04

mu/l

0.30

537

3686

Other diseases of blood and blood-forming organs, wide

430

2893

1.51

14.21

1.9

1.7

338.23

299.08

mu/l

1.19

396

2633

Cutaneous abscess, furuncle and carbuncle

754

5611

1.36

14.17

1.8

1.7

333.06

291.74

mu/l

2.37

682

5104

Other disorders of penis

171

905

1.92

14.13

1.7

1.9

269.33

266.37

mu/l

0.04

162

859

Intentional self-harm by unspecified means

388

2.61

14.13

2.0

1.6

599.09

297.97

mu/l

4.39

349

Excessive vomiting in pregnancy

380

2519

1.57

14.12

1.6

1.7

282.52

319.40

mu/l

1.12

331

2266

Malignant neoplasm of breast, ER-positive, including Hilmo

200

2599

0.57

14.06

1.9

1.8

328.15

326.08

mu/l

0.02

183

2321

Deforming dorsopathies

671

4902

1.39

14.05

1.7

284.65

310.70

mu/l

1.66

603

4438

Malignant neoplasm of breast, HER-positive

199

2588

0.57

13.98

1.9

1.8

329.28

326.71

mu/l

0.02

182

2310

Osteopathies and chondropathies

1173

8453

1.28

13.95

1.8

1.7

305.60

307.91

mu/l

0.08

1089

7687

Propionic acid derivatives

825

3083

1.36

13.92

1.6

1.8

291.97

355.08

mu/l

4.55

744

2768

Hyperkinetic disorders (excl. ADHD)

107

481

2.37

13.91

1.9

1.6

410.14

283.50

mu/l

1.12

436

Dipeptidyl peptidase 4 (DPP-4) inhibitors

666

3792

1.39

13.79

1.8

383.63

280.70

mu/l

1.41

601

3500

Enlarged lymph nodes

374

2464

1.54

13.74

1.6

1.7

279.82

289.56

mu/l

0.33

344

2247

False labour

1446

7265

1.26

13.56

1.5

1.7

288.85

339.33

mu/l

1.68

1273

6484

Benign neoplasm: Adrenal gland

135

670

2.06

13.55

2.8

1.7

299.91

307.67

mu/l

0.11

124

617

Other enthesopathies

637

4642

1.39

13.53

1.7

285.58

304.07

mu/l

0.70

586

4216

Disorders of vestibular function (Vertigo)

794

5820

1.34

13.53

1.9

1.7

299.38

304.32

mu/l

0.17

720

5289

Other septicaemia, including avohilmo

611

4144

1.39

13.45

1.8

1.7

354.05

286.02

mu/l

4.01

563

3777

Other diseases of intestine

235

1389

1.71

13.43

1.8

1.7

299.65

302.78

mu/l

0.05

217

1273

Antenatal screening

957

4122

1.32

13.32

1.5

1.8

285.66

367.20

mu/l

12.05

870

3642

Other viral diseases, including avohilmo

1449

11699

1.24

13.30

1.6

1.7

305.97

308.87

mu/l

0.12

1320

10558

Behavioural disorders, excluding more controls

106

489

2.31

13.28

2.0

1.5

449.44

257.49

mu/l

2.57

438

Other and unspecified drugs and medicaments

223

1311

1.75

13.25

1.9

1.7

377.07

297.78

mu/l

1.63

198

1180

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

304

1910

1.63

13.23

1.8

1.6

356.31

296.17

mu/l

2.03

264

1735

Diseases of salivary glands

805

6108

1.33

13.21

1.8

1.7

305.98

301.45

mu/l

0.13

731

5524

Cervical polyps

160

849

1.92

13.19

1.6

1.8

321.37

382.82

mu/l

1.47

148

752

Other bacterial intestinal infections, including avohilmo

511

3607

1.43

13.18

1.9

1.7

341.63

295.29

mu/l

1.04

462

3281

Chronic gastritis

330

2130

1.56

13.14

1.7

1.8

302.79

297.24

mu/l

0.10

295

1954

Pregnancy with abortive outcome

2173

9516

1.20

13.10

1.5

1.7

300.49

329.43

mu/l

2.77

1915

8504

Vocal cord dysfunction

318

1792

1.59

13.03

1.7

328.86

266.75

mu/l

1.83

289

1631

Diseases of liver

630

4617

1.38

12.94

1.8

286.09

289.19

mu/l

0.10

575

4217

Endometriosis ASRM stages 1,2

651

4827

1.38

12.84

1.7

1.6

317.31

311.83

mu/l

0.14

592

4294

Other complications of surgical and medical care, not elsewhere classified

254

1558

1.67

12.83

2.2

1.7

369.48

295.14

mu/l

2.18

235

1411

Diabetes medication

2879

14495

1.17

12.80

1.7

329.35

297.55

mu/l

1.74

2590

13185

Abnormal weight loss

194

1106

1.79

12.78

2.1

1.6

317.31

307.48

mu/l

0.13

179

995

Other disorders of eye and adnexa

416

2851

1.49

12.78

1.8

1.7

316.37

301.58

mu/l

0.34

382

2568

Herpesviral [herpes simplex] infections, including avohilmo

880

6805

1.31

12.76

1.7

1.6

294.46

311.38

mu/l

0.73

792

6114

Secondary polycythaemia

231

2.85

12.74

1.9

1.7

233.24

266.41

mu/l

0.62

219

Thyrotoxicosis

593

4323

1.39

12.72

1.7

291.75

304.40

mu/l

0.50

531

3893

Paralytic ileus and intestinal obstruction

358

2369

1.52

12.70

1.9

1.8

350.58

300.88

mu/l

0.77

335

2161

Other septicaemia

586

4009

1.39

12.63

1.8

1.7

356.07

285.56

mu/l

4.03

539

3653

Aplastic and other anaemias

655

4422

1.36

12.63

2.0

1.8

349.68

292.56

mu/l

2.98

607

4022

Benign neoplasm of other and ill-defined parts of digestive system

279

1754

1.61

12.58

2.0

1.7

315.56

304.40

mu/l

0.23

259

1601

Persons encountering health services for specific procedures and health care

3136

16081

1.16

12.56

1.7

337.33

299.65

mu/l

2.52

2856

14572

Use of disulfiram, acamprosate or naltrexone

224

1339

1.71

12.54

1.8

1.7

419.61

275.93

mu/l

3.45

198

1248

Haemorrhoids and perianal venous thrombosis

603

4380

1.38

12.48

1.7

293.12

297.65

mu/l

0.10

563

3961

Cluster headache, wide,, including avohilmo

199

1160

1.78

12.45

2.1

1.6

283.80

285.92

mu/l

0.03

184

1058

Radiculopathy

253

1557

1.65

12.43

1.9

1.8

306.01

316.42

mu/l

0.20

235

1416

Dislocation, sprain and strain of joints and ligaments at neck level

590

4331

1.39

12.42

1.6

1.7

310.69

300.14

mu/l

0.28

534

3915

Other noninfective gastroenteritis and colitis

607

4459

1.38

12.36

1.7

326.52

304.67

mu/l

0.73

560

4053

Candidiasis

401

2748

1.49

12.33

1.7

343.57

305.21

mu/l

0.95

359

2475

Dermatophytosis, including avohilmo

1740

14237

1.21

12.25

1.7

310.15

298.83

mu/l

0.57

1586

12928

Other intervertebral disc disorders

2055

10318

1.19

12.24

1.7

281.76

306.87

mu/l

2.06

1891

9357

Pain associated with micturition

279

1777

1.60

12.05

1.8

1.7

295.03

295.13

mu/l

0.00

256

1604

Other medical care

827

5328

1.31

12.04

1.7

1.8

388.28

293.79

mu/l

1.80

775

4830

Vasomotor and allergic rhinitis

1291

10267

1.24

12.02

1.7

300.45

316.35

mu/l

0.96

1174

9237

Cluster headache, strict, including avohilmo

195

1144

1.77

11.98

2.2

1.6

285.43

286.82

mu/l

0.02

180

1043

Malignant neoplasm of urinary organs, including Hilmo

133

685

1.97

11.97

1.6

1.9

382.44

283.73

mu/l

0.85

127

632

Superficial injury of head

567

4143

1.38

11.90

1.7

335.25

294.84

mu/l

1.36

521

3779

Spondylolisthesis/Spondylolysis

316

2074

1.54

11.83

1.8

267.82

315.38

mu/l

2.71

286

1893

Contraceptive management

1141

6384

1.26

11.76

1.6

1.8

276.84

326.18

mu/l

5.31

1025

5773

Cramp and spasm

147

795

1.92

11.76

1.7

344.67

295.81

mu/l

0.77

137

721

Internal derangement of knee

893

6909

1.29

11.72

1.6

1.7

270.01

309.00

mu/l

3.92

806

6300

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2321

13402

1.18

11.68

1.8

1.7

359.62

293.91

mu/l

4.40

2099

12189

Condition for Implicit Sepsis (Organ dysfunction codes)

1970

11522

1.19

11.65

1.9

1.7

353.18

293.84

mu/l

5.82

1771

10522

Fissure and fistula of anal and rectal regions

527

3824

1.39

11.64

1.6

1.7

300.06

295.18

mu/l

0.08

486

3465

Appendectomy

1888

15189

1.19

11.63

1.7

281.39

305.78

mu/l

2.60

1726

13740

Abnormal findings on diagnostic imaging of lung

585

4074

1.37

11.63

1.7

1.8

319.43

292.46

mu/l

0.78

534

3743

Benign neoplasm of colon, rectum, anus and anal canal

809

5261

1.31

11.57

1.9

1.8

283.34

296.10

mu/l

0.57

752

4830

Malignant neoplasm of urinary organs

116

579

2.03

11.45

1.6

1.9

388.90

284.04

mu/l

0.78

111

537

Other bacterial intestinal infections

332

2223

1.51

11.34

1.9

1.7

368.17

290.77

mu/l

1.34

307

2022

Neuralgia and neuritis, unspecified

135

717

1.94

11.33

1.7

272.80

309.06

mu/l

1.21

129

652

Injuries to the knee and lower leg

3412

16222

1.14

11.33

1.7

324.03

302.26

mu/l

1.33

3116

14677

Nontoxic multinodular goitre

248

1555

1.61

11.32

1.8

1.6

276.30

290.33

mu/l

0.34

220

1413

Benign neoplasm of brain and other parts of central nervous system

148

810

1.88

11.29

2.4

1.7

426.06

300.74

mu/l

1.26

143

735

Nerve, nerve root and plexus disorders

2719

14157

1.16

11.29

1.7

294.37

302.02

mu/l

0.25

2472

12831

Pulmonary embolism

392

2710

1.46

11.28

1.9

1.8

341.06

296.19

mu/l

1.44

358

2474

Anti-inflammatory and antirheumatic products, non-steroids

802

3083

1.32

11.27

1.7

1.8

286.39

355.08

mu/l

5.34

722

2768

Benign paroxysmal vertigo

478

3430

1.41

11.24

1.9

1.7

291.82

298.38

mu/l

0.18

432

3104

Pulmonary heart disease

392

2712

1.46

11.24

1.9

1.8

341.06

296.44

mu/l

1.43

358

2476

Abnormal serum enzyme levels

420

2839

1.44

11.22

1.9

1.8

320.88

276.19

mu/l

1.07

395

2619

Other viral diseases, not elsewhere classified, including avohilmo

947

7471

1.28

11.18

1.6

1.7

297.71

308.34

mu/l

0.52

870

6775

Injuries to the abdomen, lower back, lumbar spine and pelvis

943

7357

1.27

11.17

1.7

333.08

300.77

mu/l

1.29

865

6682

Diffuse brain injury

421

2.23

11.14

1.9

1.6

357.33

302.00

mu/l

0.85

385

Other disorders starting during childhood or adolescence

289

1894

1.58

11.06

1.8

1.6

355.00

311.54

mu/l

1.19

253

1710

Exposure to other specified factors

2344

17356

1.17

11.05

1.7

307.52

304.71

mu/l

0.12

2151

15712

Retention of urine

468

2698

1.41

11.03

1.8

357.63

280.43

mu/l

2.35

430

2465

Postpartum haemorrhage

1169

7854

1.25

10.95

1.5

1.6

322.47

330.63

mu/l

0.08

1032

6989

All influenza

574

4263

1.36

10.95

1.8

1.7

321.43

287.95

mu/l

1.28

518

3908

Anxious personality disorder

102

504

2.17

10.95

2.1

1.6

370.41

292.13

mu/l

1.06

453

Other noninflammatory disorders of uterus, except cervix

249

1034

1.62

10.94

1.8

1.9

308.06

380.86

mu/l

2.70

228

921

Explicit Sepsis, including avohilmo

840

5947

1.29

10.91

1.8

1.7

346.21

290.18

mu/l

3.79

760

5419

Cardiovascular diseases (excluding rheumatic etc)

2608

12945

1.16

10.91

1.7

1.6

303.01

304.83

mu/l

0.09

2356

11704

DVT of lower extremities and pulmonary embolism

574

4240

1.36

10.90

1.9

1.8

325.12

287.89

mu/l

1.66

524

3869

Atypical facial pain

132

707

1.92

10.83

1.8

1.7

297.24

312.23

mu/l

0.21

115

649

Other and unspecified polyneuropathies, also in other diseases

258

1651

1.58

10.83

1.8

1.7

297.01

285.98

mu/l

0.18

237

1533

Other disorders of bladder

184

1084

1.72

10.79

2.1

1.8

350.44

287.18

mu/l

0.83

163

1002

Cerebral cysts

196

1184

1.71

10.76

1.8

1.6

329.73

292.04

mu/l

0.72

178

1074

Diseases of inner ear

906

6855

1.27

10.69

1.9

1.7

294.20

302.07

mu/l

0.32

826

6246

Early onset COPD, excluding more controls

264

1701

1.56

10.68

1.6

1.8

366.40

273.64

mu/l

2.61

236

1572

Fentanyl

123

641

1.94

10.68

1.6

1.9

339.78

320.49

mu/l

0.23

117

592

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1616

7931

1.21

10.65

1.6

1.7

309.72

340.10

mu/l

0.88

1424

7085

Other and/or unspecified nontoxic goitre

129

687

1.91

10.64

2.0

1.5

286.39

294.23

mu/l

0.11

121

632

Cerebral palsy and other paralytic syndromes

260

1680

1.58

10.62

1.7

389.59

287.07

mu/l

1.79

237

1532

Mixed disorders of conduct and emotions, excluding more controls

133

730

1.94

10.55

1.8

1.4

415.66

261.91

mu/l

3.49

119

656

Polyneuropathies and other disorders of the peripheral nervous system

306

2045

1.51

10.54

1.8

1.7

285.40

286.85

mu/l

0.02

283

1889

Unspecified haematuria

595

3619

1.35

10.53

1.8

305.06

286.27

mu/l

0.83

559

3311

Explicit Sepsis

810

5765

1.29

10.50

1.8

1.7

345.98

291.51

mu/l

3.47

732

5257

Dermatitis

1490

12176

1.20

10.49

1.7

314.74

306.28

mu/l

0.32

1353

11015

Rotator cuff syndrome

1046

5774

1.25

10.49

1.7

1.8

277.47

297.64

mu/l

1.33

966

5276

Abnormal findings on diagnostic imaging of other body structures

263

1706

1.56

10.49

1.7

276.64

308.80

mu/l

1.01

245

1556

Other neurological diseases

1260

8005

1.23

10.48

1.9

1.7

312.79

297.66

mu/l

0.61

1152

7284

Redundant prepuce, phimosis and paraphimosis

371

2537

1.45

10.48

1.9

276.56

260.52

mu/l

0.49

342

2400

Non-allergic asthma (mode), excluding more controls

412

2895

1.43

10.45

1.7

313.84

303.84

mu/l

0.20

372

2640

Other neurotic disorders

465

2.12

10.45

1.7

309.15

286.29

mu/l

0.22

429

Fracture of skull and facial bones

522

3858

1.37

10.38

1.7

315.17

285.21

mu/l

1.20

467

3539

Certain disorders involving the immune mechanism

385

2704

1.44

10.37

1.9

1.7

313.94

296.26

mu/l

0.55

363

2472

Urticaria and erythema

1093

8888

1.24

10.36

1.7

301.40

309.98

mu/l

0.33

987

8012

Intestinal stricture

421

2999

1.41

10.33

1.9

1.8

336.00

297.70

mu/l

0.67

394

2745

Other and unspecified nerve root and plexus disorders, also in other diseases

458

3317

1.40

10.33

1.6

1.7

249.15

294.70

mu/l

5.00

417

3016

Benign neoplasm: Colon

642

4574

1.32

10.32

1.8

284.63

293.30

mu/l

0.29

600

4198

2390

12081

1.16

10.31

1.7

342.47

303.02

mu/l

4.23

2156

10943

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2390

12081

1.16

10.31

1.7

342.47

303.02

mu/l

4.23

2156

10943

Sequelae of injuries, of poisoning and of other consequences of external causes

550

4102

1.36

10.31

1.7

311.13

289.31

mu/l

0.88

495

3748

Necrosis of pulp, including avohilmo

1692

14164

1.19

10.29

1.8

1.7

315.09

301.95

mu/l

0.62

1478

12891

Tinnitus

437

3141

1.41

10.27

1.7

270.51

295.34

mu/l

0.95

401

2864

Benign neoplasm: Colon, unspecified

283

1870

1.53

10.27

1.7

1.8

292.78

298.19

mu/l

0.10

264

1724

Non-allergic asthma (mode)

412

2905

1.42

10.26

1.7

313.84

304.15

mu/l

0.20

372

2647

Other diseases of lip and oral mucosa

933

7461

1.26

10.22

1.7

329.72

304.11

mu/l

0.98

845

6762

Carpal tunnel syndrome

1238

8817

1.22

10.19

1.7

300.90

302.28

mu/l

0.02

1118

7987

Other arthrosis

873

4606

1.28

10.18

1.8

258.63

306.31

mu/l

4.90

807

4249

Cervicocranial syndrome

249

1609

1.57

10.18

1.8

1.7

275.91

316.70

mu/l

1.59

225

1452

Endometriosis ASRM stages 3,4

673

5184

1.32

10.18

1.6

291.13

314.61

mu/l

1.45

623

4601

Schizoid personality disorder

225

2.67

10.15

2.0

1.6

435.42

279.61

mu/l

1.72

208

Postprocedural disorders of nervous system

290

1954

1.53

10.06

1.7

1.6

304.25

293.43

mu/l

0.16

264

1757

D07AA Corticosteroids, weak (group I)

547

4100

1.36

10.02

1.7

322.31

311.55

mu/l

0.25

472

3700

Viral infections characterized by skin and mucous membrane lesions

1049

8514

1.24

9.99

1.8

1.7

307.95

300.92

mu/l

0.25

963

7734

Fall on and from stairs and steps

583

4416

1.33

9.83

1.8

1.7

337.70

297.83

mu/l

1.83

524

4013

Injuries to the head

3163

16598

1.14

9.83

1.7

329.68

300.97

mu/l

1.73

2844

15071

Missing teeth due to accident, extraction or parodontitis

973

6992

1.25

9.83

1.8

314.42

295.59

mu/l

0.78

874

6401

Mental retardation, excluding more controls

108

540

2.00

9.81

2.1

1.6

512.08

263.33

mu/l

4.50

491

Disorder of the sleep-wake schedule

375

2.27

9.80

1.7

345.18

296.63

mu/l

0.51

341

Pulmonary heart disease, diseases of pulmonary circulation

410

2935

1.41

9.79

1.9

1.8

345.26

294.47

mu/l

1.78

375

2680

Other diseases of blood and blood-forming organs

131

722

1.85

9.79

2.0

1.7

276.62

283.58

mu/l

0.12

123

662

Septicaemia

657

4599

1.31

9.78

1.8

347.80

286.94

mu/l

3.64

599

4197

Need for other prophylactic measures

135

753

1.84

9.77

1.5

1.7

276.93

281.12

mu/l

0.10

125

693

GI-bleeding

461

3369

1.38

9.73

1.9

1.8

352.14

295.82

mu/l

1.73

425

3084

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

116

615

1.91

9.69

1.6

1.9

390.18

284.26

mu/l

0.78

110

568

Strabismus

744

5823

1.29

9.69

1.9

1.7

341.27

307.36

mu/l

1.38

671

5275

Maltreatment syndromes

236

1539

1.59

9.64

1.9

1.6

381.22

288.39

mu/l

2.12

209

1404

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

112

589

1.93

9.63

2.2

1.7

334.45

310.66

mu/l

0.29

101

535

Other mental disorders due to brain damage and dysfunction and to physical disease

143

812

1.78

9.58

2.1

1.8

340.30

293.39

mu/l

0.72

126

752

Urticaria

943

7621

1.25

9.56

1.7

298.76

314.04

mu/l

0.61

849

6872

Melanocytic naevi

889

7155

1.26

9.36

1.7

1.6

303.06

306.16

mu/l

0.07

832

6432

Abnormal results of function studies

221

1423

1.59

9.28

1.9

1.7

345.37

294.45

mu/l

1.40

203

1296

Erysipelas

883

6098

1.25

9.26

1.8

334.76

277.33

mu/l

4.11

800

5590

Acute pharyngitis

648

4990

1.31

9.26

1.7

1.6

302.66

308.15

mu/l

0.14

589

4521

Malignant neoplasm of kidney, except renal pelvis

105

548

1.94

9.22

1.6

1.8

393.94

285.18

mu/l

0.71

100

507

Atopic dermatitis, strict definition with reimbursement

1273

10235

1.21

9.16

1.7

1.6

300.15

310.37

mu/l

0.55

1149

9198

Paracetamol or NSAID medication

544

2048

1.36

9.16

1.6

1.7

287.07

347.41

mu/l

2.74

495

1838

Diabetic retinopathy

359

3122

0.71

9.15

1.7

1.8

350.19

325.96

mu/l

0.41

321

2833

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

781

6233

1.28

9.09

1.6

308.13

316.29

mu/l

0.22

711

5531

Fracture of rib(s), sternum and thoracic spine

475

3530

1.36

9.08

1.8

318.87

282.57

mu/l

1.05

426

3255

Somnolence, stupor and coma

100

519

1.98

9.07

2.1

1.6

448.72

292.63

mu/l

1.39

475

Parkinson's disease, excluding more controls

453

1.98

9.04

2.1

1.9

280.08

270.54

mu/l

0.15

428

Other diseases of the digestive system

456

3369

1.36

9.03

1.9

1.8

370.30

294.24

mu/l

2.05

420

3082

Other and unspecified dermatitis

1228

10237

1.21

9.02

1.7

307.24

307.30

mu/l

0.00

1108

9264

Other problems related to primary support group, including family circumstances

476

3467

1.37

9.02

1.7

375.39

300.80

mu/l

2.65

438

3126

Zoster [herpes zoster]

294

2016

1.47

9.01

1.7

330.25

302.77

mu/l

0.53

272

1831

Dyspnoea

2139

13411

1.16

9.00

1.8

1.7

324.45

302.81

mu/l

1.64

1943

12174

Adjustment and management of implanted device

191

1193

1.61

8.95

1.9

1.8

304.78

292.69

mu/l

0.20

174

1096

Hypersomnia

210

2.63

8.93

1.3

1.5

444.94

300.00

mu/l

0.65

192

Iron deficiency

192

1225

1.66

8.91

1.5

1.7

270.84

304.33

mu/l

1.07

168

1085

Pruritus

302

2095

1.47

8.86

1.6

1.7

291.71

308.02

mu/l

0.39

279

1884

Neuromuscular dysfunction of bladder

168

1023

1.67

8.84

1.6

1.7

391.38

290.15

mu/l

1.42

150

940

Superficial injury of wrist and hand

703

5551

1.28

8.84

1.6

1.7

321.78

310.46

mu/l

0.26

633

5028

Orchitis and epididymitis

134

766

1.77

8.83

2.0

1.9

250.58

267.09

mu/l

0.36

122

727

Acne vulgaris

478

3600

1.37

8.83

1.7

1.6

328.38

318.07

mu/l

0.26

431

3245

Superficial injury of lower leg

740

5875

1.27

8.80

1.7

341.31

304.86

mu/l

0.46

676

5313

Speech and linguistic disorders

394

2760

1.40

8.76

1.9

1.7

389.05

308.46

mu/l

3.51

360

2502

Other and unspecified disorders of adult personality and behaviour

123

3.29

8.71

2.1

1.6

386.77

309.52

mu/l

0.69

111

Other disorders of eyelid

515

3670

1.33

8.70

1.8

321.52

303.51

mu/l

0.46

476

3340

Postpartum hemorraghe, parous women as controls

1169

8160

1.22

8.69

1.5

322.47

285.10

mu/l

0.51

1032

7295

Supervision of normal pregnancy

874

4015

1.26

8.66

1.5

1.8

285.37

367.00

mu/l

9.27

769

3544

Bacterial intestinal infections, IBD co-morbidities

325

2290

1.43

8.65

1.9

1.7

371.90

293.73

mu/l

1.32

301

2082

Focal epilepsy, strict definition

411

3015

1.38

8.64

1.8

1.7

356.46

291.60

mu/l

3.08

373

2750

Other follicular disorders

255

1728

1.51

8.59

1.7

300.91

285.47

mu/l

0.32

234

1549

Disorder of lipoprotein metabolism, unspecified

139

809

1.73

8.58

2.7

1.7

271.98

291.74

mu/l

0.41

131

755

Acne

601

4670

1.31

8.56

1.7

1.6

324.56

315.07

mu/l

0.27

541

4193

Abnormal blood-pressure reading, without diagnosis

111

609

1.87

8.53

1.7

1.6

285.38

287.08

mu/l

0.02

100

552

Specific development disorders of scholastic skills

229

1498

1.56

8.51

1.8

1.6

347.28

304.63

mu/l

1.03

207

1359

Other shoulder lesions

244

1637

1.52

8.51

1.8

1.7

283.80

300.46

mu/l

0.49

224

1492

Other gastritis (incl. Duodenitis)

326

2304

1.43

8.51

1.8

1.7

352.71

297.11

mu/l

1.60

298

2112

Continuous positive airway pressure

238

1311

1.52

8.48

1.5

1.8

299.27

253.20

mu/l

1.76

227

1227

Poisoning by narcotics and psychodysleptics [hallucinogens]

385

2.16

8.47

2.0

1.6

683.15

284.61

mu/l

3.04

351

Venous thromboembolism

793

6120

1.25

8.46

1.9

1.8

314.32

294.13

mu/l

0.91

722

5582

Other and unspecified trigeminal disorders

191

2.64

8.45

2.6

1.6

398.41

334.25

mu/l

0.32

178

Other and unspecified disorders of psychological development

246

2.46

8.43

2.2

1.7

500.51

304.46

mu/l

1.73

226

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

926

7576

1.24

8.43

1.6

1.7

296.41

304.16

mu/l

0.26

847

6870

Injuries to the thorax

855

6917

1.24

8.42

1.8

329.88

287.46

mu/l

1.90

780

6331

Abnormalities of gait and mobility

173

1074

1.63

8.41

1.6

1.7

317.83

307.88

mu/l

0.15

156

988

Childhood asthma (age<16), excluding more controls

781

4906

1.27

8.39

1.6

342.03

307.79

mu/l

1.26

718

4395

Volume depletion

132

763

1.75

8.39

2.0

1.6

376.97

285.44

mu/l

1.22

118

701

Childhood asthma (age<16)

781

4907

1.27

8.38

1.6

342.03

307.82

mu/l

1.26

718

4396

Lesion of ulnar nerve

274

1884

1.47

8.38

1.8

1.7

268.05

286.74

mu/l

0.57

251

1734

Elevated blood glucose level

189

1203

1.60

8.38

2.2

1.7

294.65

297.09

mu/l

0.05

173

1096

Disorders of refraction and accommodation

902

7339

1.24

8.35

1.7

323.62

309.07

mu/l

0.42

807

6645

391

2.11

8.34

2.0

1.7

289.29

302.46

mu/l

0.12

365

Faecal incontinence

128

736

1.76

8.30

1.8

1.7

299.88

317.63

mu/l

0.33

109

672

Recurrent aphthous stomatitis , including avohilmo

370

2693

1.40

8.28

1.6

1.7

302.99

304.81

mu/l

0.04

346

2430

Paralytic strabismus

122

695

1.79

8.23

2.6

1.7

365.68

297.03

mu/l

0.86

113

632

Other inflammation of vagina/vulva

178

1133

1.64

8.22

1.5

1.8

304.70

298.02

mu/l

0.14

161

1014

Disorders of sclera, cornea, iris and ciliary body

1306

11051

1.19

8.19

1.8

1.7

285.09

301.65

mu/l

1.27

1177

10039

Other symptoms and signs involving the urinary system

183

1161

1.60

8.17

1.8

413.88

294.76

mu/l

1.51

171

1060

Fibroblastic disorders

318

2254

1.42

8.17

1.7

1.8

310.45

298.99

mu/l

0.22

296

2055

Other congenital malformations, including avohilmo

443

3330

1.36

8.15

1.7

307.95

299.59

mu/l

0.24

402

3001

Otalgia

237

1598

1.52

8.13

1.9

1.6

352.35

302.94

mu/l

1.31

208

1451

Colonic or urogenital fistula

547

4224

1.31

8.11

1.6

1.7

299.68

293.56

mu/l

0.11

504

3845

Plantar fascial fibromatosis

200

1299

1.56

8.09

1.5

1.8

339.20

312.11

mu/l

0.39

185

1186

Non-small cell lung cancer, squamous

158

2.69

8.07

1.3

1.9

275.05

287.04

mu/l

0.13

144

Zoster [herpes zoster], including avohilmo

928

7342

1.23

8.07

1.8

1.7

304.35

300.90

mu/l

0.10

854

6663

Systemic connective tissue disorders

650

5132

1.28

8.05

1.7

296.96

303.96

mu/l

0.26

595

4636

Traumatic subdural haemorrhage

121

643

1.77

8.04

2.0

1.7

319.87

292.24

mu/l

0.56

109

606

Other disorders of bone

516

3965

1.32

8.02

1.6

1.7

288.38

302.47

mu/l

0.51

481

3605

Nontoxic goitre/thyroid nodule

427

3187

1.35

8.01

1.9

1.7

356.10

306.25

mu/l

0.34

388

2869

Disorders of puberty, all

104

582

1.92

7.97

2.0

1.6

442.30

323.48

mu/l

1.13

519

Disorders of puberty

452

2.04

7.95

1.8

1.4

392.78

323.68

mu/l

0.55

400

Diabetic retinopathy, excluding more controls

326

2535

0.71

7.94

1.7

1.8

350.41

328.57

mu/l

0.32

290

2296

Torsion of ovary, ovarian pedicle and fallopian tube

351

2.13

7.92

1.4

1.8

243.56

357.01

mu/l

3.06

306

Autoimmune diseases related-to ILD

2256

16604

1.14

7.91

1.8

1.7

296.76

305.33

mu/l

0.52

2051

15057

Cellulitis

498

3814

1.32

7.89

1.8

1.7

318.88

292.79

mu/l

0.83

460

3477

Other inflammation of eyelid, including avohilmo

1459

12515

1.18

7.85

1.6

1.7

294.78

307.96

mu/l

0.62

1313

11275

Heartburn

252

1730

1.48

7.83

1.5

1.7

287.15

291.67

mu/l

0.08

227

1585

Spermatocele

487

1.91

7.83

1.8

248.24

274.04

mu/l

0.55

466

Lateral epicondylitis

265

1837

1.46

7.80

1.8

1.7

300.73

297.48

mu/l

0.04

247

1679

Injury of muscle and tendon at shoulder and upper arm level

505

3877

1.31

7.77

1.7

1.8

252.12

280.94

mu/l

2.17

479

3571

ILD medications

3268

15831

1.12

7.73

1.7

291.05

306.71

mu/l

1.75

3009

14291

Carbimazole or st.post thyroidectomy, condition for graves disease

499

3842

1.31

7.65

1.6

1.7

292.40

302.64

mu/l

0.32

439

3464

Maternal care for other known or suspected fetal problems

1290

6878

1.20

7.62

1.6

1.7

305.38

335.78

mu/l

0.62

1140

6134

Noninfectious colitis NAS

327

2366

1.40

7.62

1.8

1.7

318.03

296.48

mu/l

0.52

303

2151

Delirium, not induced by alcohol and other psychoactive substances

129

760

1.71

7.60

2.2

1.7

490.48

281.79

mu/l

3.50

116

704

Mental and behavioural disorders due to hallucinogens

128

3.09

7.58

1.8

1.7

822.81

280.32

mu/l

1.76

118

Diseases of the myoneural junction and muscle

197

1294

1.54

7.57

2.0

1.7

328.47

297.95

mu/l

0.54

180

1191

Acute alcohol intoxication

541

4213

1.30

7.56

1.6

1.8

357.82

276.44

mu/l

4.29

466

3869

Labour and delivery complicated by fetal stress [distress]

1346

7482

1.19

7.53

1.5

1.6

292.79

329.29

mu/l

0.88

1202

6653

Allergic rhinitis

1143

9534

1.20

7.50

1.7

1.6

304.22

311.63

mu/l

0.31

1045

8601

Cholecystectomy

1381

10021

1.18

7.49

1.7

304.69

306.55

mu/l

0.07

1255

9044

Conduct disorder

105

598

1.85

7.46

2.0

1.6

449.49

286.93

mu/l

1.92

535

Salpingitis and oophoritis

307

2207

1.41

7.39

1.6

1.8

310.10

319.07

mu/l

0.18

277

1963

Open wound of forearm

256

1787

1.46

7.38

2.0

1.7

478.36

290.35

mu/l

6.13

226

1642

Urolithiasis

507

3925

1.30

7.37

1.9

1.8

274.04

284.56

mu/l

0.45

462

3596

Diseases of external ear

747

6059

1.24

7.37

1.7

315.08

299.08

mu/l

0.43

688

5500

Enterocolitis due to Clostridium difficile

164

1040

1.60

7.36

1.9

1.7

413.55

296.44

mu/l

1.02

153

949

Spinal stenosis

531

3027

1.30

7.36

1.9

297.29

304.71

mu/l

0.19

486

2802

Oter anti-inflammatory and antirheumatic agents, non-steroids

270

1022

1.46

7.36

1.7

2.0

267.50

336.32

mu/l

3.29

250

918

Keratitis

859

7074

1.22

7.33

1.8

1.7

279.97

298.23

mu/l

1.34

769

6423

Calculus of kidney and ureter

483

3721

1.31

7.30

1.9

1.8

275.76

285.06

mu/l

0.36

439

3409

Astigmatism

208

1399

1.52

7.30

1.8

1.6

328.34

302.44

mu/l

0.24

185

1270

Hypercalcemia

347

2.06

7.28

1.8

1.6

393.94

296.80

mu/l

1.19

319

Visual impairment including blindness (binocular or monocular)

116

676

1.74

7.27

2.2

1.6

380.65

297.78

mu/l

1.30

107

614

Other female pelvic inflammatory diseases

366

2720

1.36

7.24

1.7

310.40

316.01

mu/l

0.11

331

2416

Focal epilepsy

454

3479

1.32

7.19

1.9

1.7

354.17

292.14

mu/l

3.17

412

3163

Habit and impulse disorders

353

2.09

7.19

1.7

1.5

328.33

284.53

mu/l

0.42

319

Stomatitis and related lesions

525

4107

1.29

7.18

1.7

308.94

301.55

mu/l

0.21

483

3715

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

378

2.02

7.16

2.0

1.8

289.57

351.33

mu/l

1.29

331

Complications of surgical and medical care, not elsewhere classified

2496

14835

1.13

7.16

1.7

310.67

302.68

mu/l

0.41

2268

13454

Chronic apical periodontitis

3130

15816

1.11

7.15

1.8

1.7

317.69

299.08

mu/l

1.74

2773

14389

Rash and other nonspecific skin eruption

205

1378

1.51

7.15

2.0

1.7

334.33

293.61

mu/l

0.91

187

1247

Diabetic nephropathy, excluding more controls

149

1902

0.63

7.15

1.9

1.8

374.62

313.32

mu/l

0.94

137

1724

Gout

278

1686

1.42

7.14

1.7

1.9

336.78

292.08

mu/l

0.60

247

1574

Single delivery by caesarean section

931

4409

1.23

7.14

1.5

1.8

300.84

368.48

mu/l

4.86

827

3918

Other systemic involvement of connective tissue

508

3960

1.29

7.06

1.7

288.16

306.20

mu/l

1.00

464

3559

Other disorders of glucose regulation and pancreatic internal secretion

198

1326

1.52

7.06

1.8

1.7

387.04

287.19

mu/l

1.39

186

1214

Event of undetermined intent

206

1396

1.51

7.03

1.8

1.7

370.23

285.50

mu/l

2.49

184

1275

Acute renal failure

254

1780

1.44

7.02

2.1

1.8

424.39

281.65

mu/l

2.54

230

1649

Combinations of oral blood glucose lowering drugs

328

2401

1.38

7.02

1.6

1.8

258.05

279.25

mu/l

0.73

301

2242

Anomalies of dental arch relationship, including avohilmo

723

5321

1.25

7.02

1.7

326.12

319.08

mu/l

0.18

662

4810

Collagenous colitis

188

1247

1.53

6.99

1.7

306.84

293.88

mu/l

0.21

169

1133

Ocular pain

256

1809

1.44

6.98

1.8

1.7

303.43

295.07

mu/l

0.16

234

1627

Presbycusis

408

1.92

6.94

1.9

293.85

328.13

mu/l

0.68

376

severe traumatic brain injury, does not include concussion

289

2077

1.40

6.93

1.9

1.8

326.69

287.08

mu/l

1.55

259

1917

Dislocation, sprain and strain of joints and ligaments of knee

1834

14575

1.14

6.91

1.7

284.97

297.47

mu/l

0.99

1691

13180

Other systemic involvement of connective tissue (FG)

499

3820

1.29

6.90

1.7

288.01

307.48

mu/l

1.09

456

3455

Other and unspecified paralytic syndromes

187

2.47

6.82

1.5

1.6

390.75

284.62

mu/l

0.78

173

Complications predominantly related to the puerperium

988

8328

1.20

6.80

1.5

1.6

285.75

315.75

mu/l

1.96

876

7416

Fracture of foot, except ankle

710

5795

1.24

6.73

1.7

323.44

307.21

mu/l

0.43

645

5258

Other strabismus

649

5228

1.25

6.73

1.8

1.7

334.45

307.36

mu/l

0.95

581

4729

Other maltreatment syndromes

108

637

1.76

6.72

1.6

317.42

282.53

mu/l

0.45

103

584

Mixed hyperlipidaemia

297

2.09

6.68

1.5

1.6

280.45

281.21

mu/l

0.01

276

Benign neoplasm of mouth and pharynx

187

1251

1.52

6.67

1.8

1.7

325.81

294.62

mu/l

0.48

175

1142

Renal failure

542

3640

1.27

6.66

2.0

1.8

416.66

278.98

mu/l

6.05

496

3360

Pure hyperglyceridaemia

207

2.34

6.64

1.7

1.5

266.53

270.22

mu/l

0.03

192

Fall on same level involving ice and snow

1307

11255

1.17

6.62

1.7

308.40

305.87

mu/l

0.10

1195

10213

Benign lipomatous neoplasm

471

3668

1.29

6.61

1.9

1.7

296.14

291.95

mu/l

0.10

436

3349

Focal brain injury

100

575

1.76

6.60

2.2

1.6

330.67

288.42

mu/l

0.71

533

Other or unspecified ileus, impaction or obstruction

226

1569

1.45

6.59

1.9

1.8

372.83

304.36

mu/l

0.71

213

1439

Viral and other specified intestinal infections

872

7110

1.21

6.59

1.8

1.6

323.01

306.71

mu/l

0.57

798

6422

Gonarthrosis

1037

4920

1.20

6.57

1.7

1.8

277.04

307.74

mu/l

2.74

949

4527

Seminoma of testis, including Hilmo

113

2.90

6.56

1.6

1.7

240.04

256.77

mu/l

0.23

106

Other viral diseases, not elsewhere classified

524

4136

1.28

6.55

1.7

306.46

298.77

mu/l

0.23

475

3758

Non-small cell lung cancer, squamous, helper endpoint

176

2.41

6.54

1.3

1.8

275.05

278.85

mu/l

0.05

163

Thyrotoxicosis with toxic multinodular goitre

460

1.86

6.54

1.7

244.86

312.23

mu/l

2.43

416

Vulvovaginal ulceration/inflammation in other diseases

295

2169

1.40

6.52

1.6

1.7

295.38

306.62

mu/l

0.21

268

1918

Car occupant injured in other and unspecified transport accidents

602

4851

1.26

6.51

1.5

1.7

296.25

297.32

mu/l

0.03

551

4389

Routine general health check-up of defined subpopulation

393

1.95

6.48

1.8

1.9

367.33

315.16

mu/l

0.36

349

Complications of internal orthopaedic prosthetic devices, implants and grafts

230

1608

1.44

6.48

1.8

284.86

302.91

mu/l

0.45

212

1483

Anogenital herpesviral [herpes simplex] infection

292

2149

1.40

6.46

1.6

1.7

292.60

290.89

mu/l

0.04

270

1923

Acute pancreatitis

301

2207

1.38

6.46

1.8

1.7

308.87

287.84

mu/l

0.49

279

2027

Other viral diseases

976

8219

1.20

6.45

1.7

315.90

309.33

mu/l

0.21

882

7451

Ehlers-Danlos syndrome, including avohilmo

385

2.01

6.44

2.0

1.7

297.33

317.21

mu/l

0.34

347

Shoulder lesions

1475

7658

1.16

6.43

1.7

286.13

299.87

mu/l

0.86

1366

6974

Dermatographic urticaria

223

1566

1.46

6.38

1.9

1.7

279.62

298.69

mu/l

0.59

199

1402

Symptoms and signs involving appearance and behaviour

145

2.66

6.35

2.3

1.6

530.77

319.05

mu/l

0.99

133

Parkinson's disease, strict definition, excluding more controls

410

1.85

6.35

2.2

1.9

249.88

271.55

mu/l

0.44

387

Viral warts, including avohilmo

680

5566

1.24

6.34

1.7

298.85

308.35

mu/l

0.27

632

5041

Other symptoms and signs involving the digestive system and abdomen

311

2301

1.36

6.33

2.1

1.7

304.99

310.61

mu/l

0.13

279

2083

Fungal Sepsis

430

1.88

6.32

2.1

1.7

386.45

283.80

mu/l

0.91

393

Other disorders of the musculoskeletal system and connective tissue

233

1644

1.43

6.31

1.7

302.05

296.51

mu/l

0.11

213

1517

Unspecified fall

1123

9425

1.18

6.28

1.7

317.54

305.24

mu/l

0.50

1000

8590

Localized swelling, mass and lump of skin and subcutaneous tissue

651

5301

1.24

6.27

1.8

1.7

280.10

298.22

mu/l

0.88

605

4800

Intestinal malabsorption

117

716

1.67

6.27

2.3

1.7

302.26

288.51

mu/l

0.16

105

652

Special screening examination for other diseases and disorders

279

2033

1.39

6.27

1.6

1.7

317.72

299.99

mu/l

0.37

255

1814

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1436

12372

1.16

6.25

1.6

1.7

290.65

307.36

mu/l

1.36

1296

11157

Secondary hypertension

149

949

1.57

6.24

2.1

1.6

345.99

279.32

mu/l

1.12

136

869

Hypoglycaemia, other or unspecified

164

1087

1.54

6.22

1.7

410.26

292.46

mu/l

1.37

155

992

Behavioural disorders

106

640

1.74

6.21

2.0

1.6

449.44

293.08

mu/l

1.85

576

Memory loss

563

1.74

6.20

2.3

1.7

287.09

284.30

mu/l

0.04

519

Diagnoses used for exclusion with ILD

357

2703

1.33

6.19

1.9

1.8

324.85

293.34

mu/l

0.84

331

2484

Hypermobility syndrome

231

1648

1.45

6.18

1.6

289.73

302.32

mu/l

0.35

214

1476

Congenital malformations of genital organs

382

2921

1.33

6.18

1.7

1.6

316.87

302.55

mu/l

0.30

351

2607

Subacute thyroiditis

517

1.79

6.10

1.7

1.4

282.57

279.30

mu/l

0.04

468

Ehlers-Danlos syndrome

308

2.11

6.09

1.6

1.7

288.62

316.11

mu/l

0.45

281

Heart failure and antihypertensive medication

292

1384

1.38

6.04

1.8

340.38

281.72

mu/l

1.94

262

1283

Melanocytic naevi of trunk

324

2437

1.35

6.04

1.8

1.7

316.50

294.60

mu/l

0.34

306

2198

Thyroiditis

188

1291

1.49

6.03

1.8

1.7

332.49

294.59

mu/l

0.55

163

1174

Cerebrovascular diseases (FINNGEN)

559

3134

1.26

6.02

1.9

1.7

300.23

284.78

mu/l

0.67

508

2857

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

203

1409

1.45

6.01

1.7

1.8

285.53

293.26

mu/l

0.14

194

1284

Ptosis of eyelid

141

910

1.57

5.95

1.7

377.58

300.69

mu/l

0.95

125

832

Other facial nerve disorders

368

1.93

5.95

1.8

1.5

335.91

282.15

mu/l

0.39

338

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

111

466

1.68

5.93

1.3

1.8

306.64

314.35

mu/l

0.09

425

Other specified and unspecified disorders of eye and adnexa

484

1.80

5.93

1.9

1.6

410.70

297.09

mu/l

0.94

443

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

401

3101

1.31

5.93

1.6

1.7

319.85

303.26

mu/l

0.50

363

2815

Other abnormal findings of blood chemistry

112

688

1.67

5.92

1.8

1.6

363.34

300.71

mu/l

0.41

102

622

Other and unspecified local infections of skin and subcutaneous tissue

218

1542

1.43

5.92

1.7

345.68

286.81

mu/l

0.79

191

1406

Implicit fungal Sepsis

404

1.87

5.90

2.1

1.7

385.95

287.46

mu/l

0.78

369

Other congenital malformations

298

2226

1.37

5.90

1.8

1.6

321.86

300.34

mu/l

0.65

266

2009

Type1 diabetes, definitions combined, early onset

153

2250

0.66

5.89

1.7

304.16

295.40

mu/l

0.18

133

2048

Acute alcohol intoxication, ICD10

492

3919

1.27

5.88

1.7

362.04

286.23

mu/l

3.35

421

3598

Thiazolidinediones

117

725

1.63

5.86

1.7

1.8

322.73

296.00

mu/l

0.30

107

675

Other local infections of skin and subcutaneous tissue

227

1621

1.42

5.84

1.7

343.47

285.45

mu/l

0.82

199

1478

COPD (mode)

292

1679

1.36

5.83

1.6

1.9

330.85

273.60

mu/l

1.55

267

1551

Other hearing loss

303

2187

1.35

5.83

1.9

1.8

298.58

298.18

mu/l

0.01

283

2004

Other and unspecified myopathies

121

758

1.62

5.83

1.9

1.7

329.25

286.96

mu/l

0.50

109

703

Other benign neoplasms of skin

622

5083

1.23

5.80

1.8

1.7

320.24

297.80

mu/l

0.71

571

4609

Infective dermatitis

225

1606

1.42

5.79

1.8

1.7

345.17

295.82

mu/l

0.68

205

1463

Noninfective enteritis and colitis

1156

9971

1.16

5.78

1.7

303.20

305.44

mu/l

0.08

1064

9055

Unspecified privation

239

1726

1.40

5.77

1.8

1.7

395.76

292.39

mu/l

2.46

222

1575

Unspecified abortion

109

670

1.66

5.75

1.6

1.7

294.05

346.36

mu/l

1.38

102

604

Enthesopathies of lower limb, excluding foot

475

3776

1.27

5.74

1.7

1.8

286.40

307.81

mu/l

0.58

439

3427

Acute pancreatitis (for exclusion)

301

2252

1.35

5.73

1.8

1.7

308.87

286.08

mu/l

0.55

279

2072

All influenza (not pneumonia)

342

2611

1.32

5.71

1.8

1.7

298.66

286.38

mu/l

0.29

309

2397

Papilloedema, unspecified

471

1.81

5.69

1.5

1.6

282.19

303.70

mu/l

0.35

432

ILD medications: prednisolone, methylprednisolone, prednisone

3022

15299

1.10

5.68

1.7

294.17

306.09

mu/l

1.07

2795

13823

Atopic dermatitis, strict definition

1216

10346

1.16

5.64

1.7

1.6

299.91

314.13

mu/l

0.83

1099

9301

Chronic kidney disease

328

2391

1.33

5.64

1.9

1.8

445.25

283.41

mu/l

4.18

305

2207

Other and unspecified tonsillitis

1416

10331

1.15

5.63

1.7

1.6

303.23

302.51

mu/l

0.01

1285

9346

Gout, FINNGEN

278

2044

1.36

5.63

1.7

1.8

336.78

280.33

mu/l

0.83

247

1910

Atrial fibrillation and flutter with reimbursement

289

1343

1.36

5.61

1.8

1.7

261.91

269.13

mu/l

0.22

268

1248

Thyrotoxicosis with diffuse goitre

330

2516

1.33

5.60

1.7

1.5

277.25

291.20

mu/l

0.45

286

2273

Long labour

1024

7458

1.18

5.58

1.5

1.6

277.68

328.17

mu/l

6.09

909

6633

Papulosquamous disorders

718

5981

1.21

5.54

1.7

1.8

283.26

295.05

mu/l

0.38

649

5445

Gout, unspecified

197

1381

1.44

5.54

1.8

318.10

270.93

mu/l

1.00

175

1302

Diseases of appendix

1949

15599

1.12

5.50

1.7

281.49

304.17

mu/l

2.33

1782

14125

Hemiplegia

102

624

1.67

5.48

1.7

1.6

375.64

300.26

mu/l

0.84

574

Agranulocytosis

194

1364

1.44

5.45

1.8

1.7

366.32

301.93

mu/l

1.29

178

1238

Appendicitis, broad definition

1939

15580

1.12

5.44

1.7

281.65

304.26

mu/l

2.30

1772

14107

Benign neoplasm of bone and articular cartilage

208

1485

1.42

5.43

1.7

307.93

296.34

mu/l

0.17

192

1353

Trigeminal neuralgia

121

774

1.59

5.42

2.2

1.7

307.74

306.87

mu/l

0.01

109

707

Arthrosis

1432

6869

1.15

5.41

1.7

1.8

269.61

302.17

mu/l

3.85

1322

6290

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2398

14611

1.11

5.41

1.8

1.7

324.96

300.78

mu/l

2.20

2204

13251

Other blood glucose lowering drugs, excl. Insulins

153

1027

1.50

5.40

1.6

1.8

286.23

294.72

mu/l

0.15

138

956

Premature rupture of membranes

1051

6454

1.17

5.37

1.5

1.7

284.64

336.08

mu/l

4.99

926

5763

Status epilepticus

352

1.88

5.34

1.7

1.5

449.31

296.14

mu/l

1.74

327

Superficial injury of abdomen, lower back and pelvis

433

3448

1.27

5.27

1.7

336.28

297.18

mu/l

0.82

394

3132

Solid cancers

1436

9550

0.88

5.24

1.8

1.7

306.44

298.57

mu/l

0.31

1347

8644

Other inflammation of eyelid

276

2071

1.35

5.24

1.6

1.7

287.50

297.20

mu/l

0.25

249

1876

Spondylopathies

1436

7459

1.14

5.22

1.7

1.8

286.08

305.28

mu/l

1.25

1306

6793

Ulcer of vagina/vulva

102

637

1.66

5.22

1.7

1.6

381.34

303.45

mu/l

0.90

564

Diseases of tongue

104

647

1.63

5.21

2.1

1.8

256.99

279.20

mu/l

0.50

589

Alcohol abuse, main dg

384

3020

1.29

5.19

1.7

356.61

284.94

mu/l

2.36

329

2766

Bacterial pneumonia (organism specified)

757

5766

1.19

5.18

1.7

1.8

317.71

293.61

mu/l

0.98

692

5272

Benign neoplasm: Rectum

192

1359

1.42

5.17

2.0

1.8

274.93

308.39

mu/l

0.90

176

1255

Other complications of labour and delivery, not elsewhere classified

775

5834

1.20

5.17

1.4

1.6

281.41

326.51

mu/l

3.07

689

5180

Dependent personality disorder

245

2.07

5.16

2.2

1.5

462.00

282.40

mu/l

1.28

222

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

121

783

1.57

5.15

2.4

1.7

416.83

290.54

mu/l

1.75

114

714

Dissocial personality disorder

260

2.05

5.14

1.6

458.52

272.52

mu/l

1.16

244

Seminoma of testis

2.83

5.14

1.4

1.7

248.84

247.95

mu/l

0.01

Extreme obesity with alveolar hypoventilation

408

1.80

5.14

1.5

1.7

451.42

296.01

mu/l

1.07

373

Malignant neoplasm of endocrine gland, including Hilmo

164

1133

1.47

5.12

2.3

1.7

315.19

298.45

mu/l

0.27

153

1015

Acute appendicitis

1835

15266

1.12

5.12

1.7

281.84

304.07

mu/l

2.12

1677

13821

Diabetic retinopathy, strict definition

213

2584

0.72

5.10

1.7

1.8

354.35

329.15

mu/l

0.31

182

2350

Malignant neoplasm of brain, including Hilmo

598

1.65

5.09

2.7

1.7

432.39

295.70

mu/l

1.44

547

Other and unspecified follicular disorders

113

725

1.60

5.09

1.6

309.69

290.47

mu/l

0.22

104

661

Other disorders of kidney and ureter

180

1267

1.43

5.04

1.7

406.03

294.69

mu/l

1.23

173

1171

Other enthesopathy of foot (+metatarsalgia)

224

1640

1.38

5.03

1.7

300.82

309.84

mu/l

0.13

202

1485

Obstructed labour due to malposition and malpresentation of fetus

900

7162

1.18

5.00

1.5

1.7

271.88

329.65

mu/l

6.21

813

6363

Autonomic disorders

340

1.88

4.99

1.9

1.7

330.53

285.24

mu/l

0.46

311

Focal epilepsy, mode (most common among epilepsy diagnosis)

372

2927

1.28

4.97

1.8

1.7

350.16

291.71

mu/l

2.36

338

2668

Hyperkalaemia

331

1.86

4.96

1.6

401.43

266.63

mu/l

1.05

310

Coagulation defects, purpura and other haemorrhagic conditions

425

3400

1.26

4.96

1.6

1.7

307.14

298.68

mu/l

0.20

385

3085

Fall on same level

3316

16276

1.09

4.93

1.7

311.82

303.50

mu/l

0.56

3014

14743

Chronic periodontitis, complicated

863

7189

1.17

4.93

1.8

296.27

290.93

mu/l

0.16

764

6595

Disorders of synovium and tendon

1312

9797

1.14

4.93

1.7

298.69

308.14

mu/l

0.15

1200

8865

Liquid cancers, including Hilmo

450

3185

1.25

4.91

1.9

1.8

310.24

289.55

mu/l

0.71

431

2903

Specific development disorders of speech and language

207

1452

1.40

4.91

1.9

1.7

430.98

304.11

mu/l

3.76

189

1314

Problems related to social environment

499

1.71

4.88

1.7

450.87

303.92

mu/l

1.38

456

Viral pneumonia

256

1923

1.35

4.86

1.8

1.7

347.89

284.54

mu/l

1.48

235

1764

Other and unspecified papulosquamous disorders

3.44

4.85

1.1

1.8

229.06

293.00

mu/l

0.84

Sacrococcygeal disorders, not elsewhere classified

523

1.69

4.84

1.9

1.8

285.40

307.07

mu/l

0.38

470

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

505

1.73

4.82

2.0

1.6

299.17

314.85

mu/l

0.31

456

Hernia of abdominal wall

797

6791

1.18

4.81

1.7

281.00

290.24

mu/l

0.41

734

6193

Otitis externa, unspecified

303

2338

1.31

4.81

1.8

1.6

324.86

298.52

mu/l

0.37

282

2116

Bacterial pneumoniae

721

5342

1.19

4.78

1.7

319.98

288.84

mu/l

1.36

659

4888

Other disorders of patella

454

3678

1.25

4.78

1.6

1.7

271.32

306.68

mu/l

1.74

414

3339

Haemorrhage, not elsewhere classified

279

1.93

4.77

1.6

1.7

332.64

289.82

mu/l

0.50

261

Statin medication

1882

9521

1.12

4.76

1.7

316.18

294.01

mu/l

1.73

1712

8649

Raynaud syndrome

247

1857

1.35

4.76

1.7

260.85

294.42

mu/l

1.13

222

1666

Disorders of puberty, other/unspecified

2.88

4.75

2.1

1.5

550.88

336.59

mu/l

0.58

Complications of labour and delivery

1847

9219

1.12

4.73

1.5

1.7

315.12

334.21

mu/l

0.55

1650

8202

Paroxysmal tachycardia

495

3355

1.23

4.71

1.9

1.7

313.60

295.32

mu/l

0.42

439

3040

Otitis externa

540

4459

1.22

4.71

1.7

313.59

300.51

mu/l

0.27

498

4037

Birth trauma

169

2.33

4.70

1.6

247.37

336.81

mu/l

2.28

158

Bell's palsy

229

1702

1.36

4.69

2.0

1.7

287.39

296.88

mu/l

0.17

206

1547

Follicular cysts of skin and subcutaneous tissue

360

2845

1.28

4.68

1.9

1.7

294.50

289.39

mu/l

0.10

330

2589

Malignant neoplasm

1539

10101

0.89

4.66

1.8

1.7

305.85

298.04

mu/l

0.33

1450

9147

Inflammatory disorders of breast

272

2088

1.33

4.65

1.6

1.7

385.66

301.53

mu/l

1.27

237

1850

Blepharochalasis

272

2071

1.32

4.64

1.7

1.9

302.06

313.28

mu/l

0.18

254

1892

Gout, idiopatic and unspecified

233

1735

1.35

4.64

1.7

1.8

301.26

271.04

mu/l

0.66

208

1628

Other disorders of breast and lactation associated with childbirth

114

762

1.59

4.62

1.5

1.6

266.87

290.35

mu/l

0.33

108

680

Heterophoria

251

1902

1.34

4.61

1.8

1.6

288.16

298.22

mu/l

0.27

219

1721

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

186

1342

1.40

4.60

1.6

1.7

310.59

286.46

mu/l

0.43

161

1217

Congenital malformations of the musculoskeletal system, not elsewhere classified

405

1.79

4.60

1.7

1.6

295.00

320.20

mu/l

0.48

373

Varicose veins of other sites

113

741

1.55

4.59

1.9

1.8

240.66

266.38

mu/l

0.69

108

697

Major anomalies of jaw size

478

1.70

4.59

2.0

1.7

317.38

296.02

mu/l

0.18

436

Respiratory conditions due to other external agents

104

2.55

4.58

1.7

1.5

311.46

294.56

mu/l

0.13

Atrial fibrillation and flutter

453

2358

1.25

4.58

1.8

1.7

277.18

275.17

mu/l

0.05

424

2168

Striking against or struck by other objects

964

8365

1.16

4.58

1.7

312.18

300.31

mu/l

0.42

867

7635

Nonsuppurative otitis media, including avohilmo

1288

9864

1.14

4.58

1.7

1.6

315.26

306.92

mu/l

0.37

1159

8893

Malignant neoplasm of endocrine gland

144

994

1.47

4.57

2.2

1.7

326.48

293.68

mu/l

0.54

134

894

Primary_lymphoid and hematopoietic malignant neoplasms

289

2226

1.31

4.56

1.9

1.8

314.47

294.13

mu/l

0.51

276

2050

Diseases of oesophagus, stomach and duodenum

2681

14503

1.09

4.56

1.8

1.7

303.15

302.50

mu/l

0.03

2445

13149

Fracture at wrist and hand level

863

7418

1.17

4.54

1.7

285.10

297.55

mu/l

0.58

801

6772

Acute appendicitis, no complications

1534

13649

1.12

4.53

1.7

281.31

300.40

mu/l

1.44

1399

12349

Neuroendocrine tumor and carcinoma of lung

3.53

4.52

2.9

1.6

265.73

315.50

mu/l

0.35

Hypertrophic disorders of skin

188

1369

1.40

4.51

1.7

319.13

296.99

mu/l

0.38

173

1239

Liquid cancers

352

2631

1.27

4.51

1.9

1.8

314.69

290.85

mu/l

0.72

338

2398

Medicines for HER+ breast cancer

500

3824

1.22

4.51

1.7

1.8

277.01

321.74

mu/l

2.03

471

3432

Glaucoma suspect

409

3291

1.25

4.48

2.0

1.8

305.64

298.12

mu/l

0.16

368

3021

Hallux rigidus

148

1029

1.45

4.46

1.7

1.8

241.53

321.33

mu/l

5.85

131

954

Speech therapy

388

3113

1.25

4.43

1.7

307.72

297.69

mu/l

0.25

360

2835

Mixed disorders of conduct and emotions

133

922

1.51

4.41

1.8

1.6

415.66

302.90

mu/l

2.07

119

828

114

768

1.56

4.40

1.8

1.6

366.14

311.53

mu/l

0.88

687

Other surgical follow-up care

105

688

1.57

4.39

1.7

377.01

297.89

mu/l

0.69

615

Conjunctivitis (acute, non atopic)

778

6651

1.17

4.37

1.7

306.10

307.54

mu/l

0.04

708

6017

Atrophic disorders of skin

301

2352

1.29

4.33

1.8

1.7

284.48

308.27

mu/l

1.00

281

2111

Metatarsalgia

201

1486

1.37

4.31

1.7

301.45

311.00

mu/l

0.13

180

1345

Congenital malformations of uterus and cervix

114

771

1.55

4.30

1.4

1.7

278.08

296.86

mu/l

0.19

102

686

Bacterial pneumonia, not elsewhere classified

664

4937

1.19

4.29

1.6

1.7

321.34

288.34

mu/l

1.38

610

4518

Disorders of vitreous body and globe

609

4842

1.19

4.28

1.9

1.8

287.71

301.91

mu/l

0.61

557

4426

Erysipelas, including avohilmo

1275

8371

1.13

4.27

1.8

1.7

328.56

285.64

mu/l

3.60

1162

7654

Hypertrophic scar

174

1264

1.41

4.27

1.7

324.53

300.87

mu/l

0.37

159

1144

Polyarthropathies

1328

9576

0.89

4.25

1.7

292.01

310.59

mu/l

0.98

1205

8701

Ganglion

515

4280

1.21

4.25

1.7

278.15

309.61

mu/l

1.67

477

3860

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1686

11808

0.90

4.24

1.7

298.14

297.93

mu/l

0.01

1530

10743

Intussusception

242

1.95

4.23

1.7

1.6

303.71

308.27

mu/l

0.03

216

Other and unspecified disorders of vitreous body

438

3495

1.23

4.23

1.8

273.61

312.10

mu/l

2.48

396

3200

Other superficial mycoses, including avohilmo

370

2983

1.26

4.20

1.6

1.7

360.45

298.86

mu/l

0.35

340

2694

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

233

1767

1.33

4.20

1.9

1.7

295.42

298.88

mu/l

0.05

216

1623

Disorders of vitreous body

588

4698

1.19

4.19

1.9

1.8

287.61

301.98

mu/l

0.60

537

4294

Maternal care for known or suspected malpresentation of fetus

961

5997

1.16

4.19

1.5

1.7

275.89

335.61

mu/l

5.61

850

5341

Malignant neoplasm

1547

10084

0.89

4.19

1.8

1.7

304.44

298.01

mu/l

0.27

1458

9134

Nasal polyp

294

2300

1.29

4.18

1.7

1.8

272.97

288.06

mu/l

0.35

275

2102

Osteonecrosis

550

1.60

4.17

1.9

1.6

317.78

294.31

mu/l

0.34

509

Sequelae of injuries of head

118

800

1.50

4.17

1.8

1.6

394.36

286.07

mu/l

2.20

102

734

Torsion of testis

287

1.87

4.16

2.0

1.8

315.80

284.25

mu/l

0.21

270

Other peripheral vascular diseases

173

1258

1.39

4.15

1.7

1.6

258.84

286.20

mu/l

0.71

158

1144

Benign leiomyoma with endometriosis

211

1580

1.35

4.14

1.8

1.7

329.59

324.02

mu/l

0.11

191

1409

Malnutrition

223

1.98

4.13

2.0

1.5

305.97

303.98

mu/l

0.01

207

Solid cancers, including Hilmo

1585

10255

0.90

4.12

1.9

1.7

298.02

297.81

mu/l

0.01

1489

9288

Pacemaker

310

2267

1.27

4.12

1.8

295.33

294.97

mu/l

0.01

286

2087

Other diseases of stomach and duodenum

544

1.60

4.11

2.0

1.8

340.37

306.42

mu/l

0.39

500

Other congenital malformations of skin, including avohilmo

236

1805

1.33

4.11

1.7

299.07

294.74

mu/l

0.08

213

1632

Other specified/unspecified arthritis

552

4631

1.20

4.10

1.7

286.37

310.68

mu/l

1.28

513

4213

STROKE

845

4915

1.16

4.09

1.9

1.8

300.09

287.21

mu/l

0.45

775

4514

Adhesive capsulitis of shoulder

221

1669

1.33

4.08

1.7

284.48

306.29

mu/l

0.41

206

1529

Unspecified kidney failure

102

671

1.53

4.08

1.8

1.6

466.05

282.38

mu/l

1.86

622

Ventral hernia

332

2645

1.26

4.06

1.7

268.67

299.60

mu/l

1.61

308

2411

Other skin changes

312

2471

1.27

4.03

1.7

314.83

303.32

mu/l

0.23

290

2235

Diabetic nephropathy

150

2054

0.71

4.03

1.9

1.8

374.62

314.87

mu/l

0.91

137

1862

Other specified/unspecified hearing loss

116

787

1.49

4.03

2.0

1.7

326.87

307.47

mu/l

0.25

109

727

Sicca syndrome [Sjögren]

137

961

1.44

4.03

1.4

1.7

278.38

305.70

mu/l

0.93

122

870

Heart failure, not strict

975

5725

1.15

4.03

1.9

1.8

338.94

286.57

mu/l

4.36

892

5276

Fracture of lower leg, including ankle

1136

9880

1.13

4.02

1.7

328.90

298.29

mu/l

1.91

1033

8990

Lactose intolerance

567

1.59

3.99

1.7

1.6

326.04

298.94

mu/l

0.20

509

Impingement syndrome of shoulder

290

2278

1.28

3.99

1.8

292.53

299.50

mu/l

0.13

267

2081

Seborrhoeic dermatitis

187

1386

1.36

3.97

1.8

1.7

365.23

290.08

mu/l

0.89

171

1273

Other specified/unspecified inflammatory spondylopathies

137

968

1.44

3.95

1.9

1.7

308.48

298.80

mu/l

0.11

126

869

Cardiac arrhythmias

1735

10072

1.11

3.95

1.7

1.6

284.03

298.70

mu/l

1.13

1580

9144

Oxicams

395

1812

1.24

3.95

1.6

1.9

280.67

338.06

mu/l

2.43

359

1627

Dystonia

113

769

1.49

3.93

1.8

1.7

310.10

315.38

mu/l

0.05

104

702

Other disorders of binocular movement

556

1.60

3.93

1.8

1.7

285.31

301.78

mu/l

0.17

495

Deep endometriosis

267

2091

1.30

3.90

1.5

1.6

287.56

300.70

mu/l

0.34

247

1853

Hypertrophy of breast

429

3538

1.22

3.90

1.7

308.42

312.58

mu/l

0.09

387

3153

Other symptoms and signs involving the circulatory and respiratory systems

130

910

1.45

3.89

1.7

307.77

294.18

mu/l

0.20

120

827

Open wound of hip and thigh

627

1.55

3.88

1.6

1.7

371.86

281.06

mu/l

1.31

576

Other peripheral vertigo

134

943

1.44

3.87

1.8

1.7

357.47

301.35

mu/l

0.68

119

863

Type 1 diabetes, strict definition

184

2438

0.74

3.87

1.5

1.7

300.65

289.33

mu/l

0.29

161

2222

Disorders of eyelid, lacrimal system and orbit

1944

12989

1.10

3.87

1.7

302.53

307.45

mu/l

0.22

1758

11770

Corneal ulcer

434

3585

1.22

3.87

1.9

1.7

282.20

295.51

mu/l

0.52

386

3267

Benign neoplasm: Rectosigmoid junction

242

1.88

3.86

1.8

218.13

271.70

mu/l

1.61

223

Other disorders of conjunctiva

183

1357

1.36

3.85

2.0

1.7

308.55

298.98

mu/l

0.14

169

1235

Eustachian salpingitis and obstruction

269

2114

1.29

3.85

1.6

1.7

266.33

286.82

mu/l

0.62

239

1933

Transient ischemic attack

529

3528

1.20

3.85

2.0

1.8

288.65

291.27

mu/l

0.05

484

3240

Hidradenitis suppurativa

142

1018

1.43

3.85

1.8

1.6

292.17

288.44

mu/l

0.05

131

923

Other and unspecified coagulation defects

153

1109

1.41

3.84

1.4

1.7

280.69

293.26

mu/l

0.23

138

999

Nail disorders

191

1430

1.35

3.84

1.8

1.7

280.65

295.98

mu/l

0.35

182

1300

Congenital malformations and deformations of the musculoskeletal system

311

2475

1.27

3.83

1.6

1.7

310.13

302.45

mu/l

0.20

279

2245

Open wound of lower leg

323

2590

1.26

3.81

1.8

1.7

397.48

288.48

mu/l

2.69

293

2364

Pregnancy, childbirth and the puerperium

859

3900

1.16

3.80

1.6

1.8

300.36

381.04

mu/l

9.52

763

3466

Benign neoplasm: Rectum, anus and anal canal

208

1575

1.33

3.79

2.1

1.8

276.02

304.29

mu/l

0.77

190

1453

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

307

1.82

3.78

1.5

1.7

421.76

271.70

mu/l

0.97

269

Covid-19 suspected case

683

5886

1.17

3.78

1.6

1.7

303.44

307.72

mu/l

0.11

623

5309

Acute nasopharyngitis (common cold)

270

2106

1.28

3.77

1.8

1.6

265.29

265.30

mu/l

0.00

248

1940

Other arrhythmias

1449

9741

1.11

3.76

1.8

1.7

292.32

302.78

mu/l

0.49

1329

8839

Benign neoplasm: Other/unspecified site

155

2.12

3.74

2.1

1.7

286.32

293.55

mu/l

0.06

143

Central nervous system disorder causing precocious puberty

2.71

3.73

1.7

1.5

527.36

306.16

mu/l

0.75

Unspecified lump in breast

296

2357

1.27

3.72

1.6

1.7

325.13

315.43

mu/l

0.16

262

2095

Sequelae of injuries of upper limb

202

1532

1.33

3.72

1.6

1.7

299.76

287.32

mu/l

0.21

179

1403

Other disorders of skin and subcutaneous tissue

1377

10451

1.12

3.71

1.7

297.94

302.81

mu/l

0.22

1266

9491

Benign neoplasm of other and unspecified sites

373

1.70

3.70

1.9

1.7

264.52

300.14

mu/l

0.77

340

Autoimmune hepatitis, wide definition

649

1.52

3.70

1.9

1.6

263.63

289.09

mu/l

0.35

599

Other noninflammatory disorders of cervix uteri

320

1.74

3.66

1.5

1.9

263.23

384.11

mu/l

2.57

282

Abnormal findings on antenatal screening of mother

497

4206

1.21

3.66

1.5

1.6

253.81

324.83

mu/l

4.70

444

3755

Familial hypercholesterolemia

128

902

1.43

3.66

1.8

1.7

293.48

287.11

mu/l

0.08

123

838

Other papulosquamous disorders

130

2.23

3.66

1.4

1.6

236.61

316.74

mu/l

1.95

118

Pollen allergy

764

6569

1.16

3.64

1.7

1.6

308.09

314.11

mu/l

0.18

689

5921

Oral corticosteroids

2755

14976

1.08

3.62

1.7

297.82

305.27

mu/l

0.50

2535

13535

Iron deficiency anaemia secondary to blood loss (chronic)

214

1640

1.31

3.62

1.9

1.7

353.90

297.37

mu/l

1.35

187

1498

Psoriasis

529

4479

1.19

3.59

1.8

1.7

286.24

291.38

mu/l

0.11

478

4065

Inflammatory bowel disease treatment related agents

3128

16164

1.08

3.59

1.7

289.02

306.58

mu/l

2.14

2881

14603

Any event in cancer register

2118

13443

0.92

3.59

1.8

1.6

301.94

299.64

mu/l

0.11

1968

12128

Fracture of lumbar spine and pelvis

293

2333

1.26

3.57

1.9

1.8

343.80

298.54

mu/l

1.17

272

2117

Cardiodefibrillation

295

2348

1.26

3.57

1.8

282.27

290.26

mu/l

0.20

274

2185

Periapical abscess

969

8579

1.13

3.56

1.9

1.7

303.27

292.24

mu/l

0.53

864

7839

Postprocedural musculoskeletal disorders, not elsewhere classified

540

1.55

3.56

1.6

1.7

310.05

291.04

mu/l

0.20

498

Varicose veins

576

5097

0.85

3.56

1.7

1.8

326.97

301.86

mu/l

0.68

528

4651

Cerebral aneurysm, nonruptured

122

859

1.43

3.55

2.0

1.7

268.05

293.25

mu/l

0.67

110

791

Benign neoplasm: Sigmoid colon

192

1453

1.33

3.55

1.8

267.07

308.11

mu/l

1.32

174

1341

Amblyopia ex anopsia

123

872

1.44

3.54

2.0

1.5

331.79

300.66

mu/l

0.63

112

778

Superficial injury of forearm

304

2450

1.26

3.52

1.7

1.6

334.71

299.32

mu/l

0.56

269

2219

Polyglandular hyperfunction

13.43

3.52

6.0

1.5

354.33

301.00

mu/l

—

Other specified/unspecified soft tissue disorders

463

1.60

3.52

1.5

1.6

264.04

321.42

mu/l

1.95

424

Sequelae of other external causes

112

780

1.46

3.50

1.6

1.7

309.57

294.71

mu/l

0.21

105

711

Abscess of anal and rectal regions

184

1393

1.34

3.46

1.8

1.7

298.50

293.70

mu/l

0.06

175

1269

Mixed specific developmental disorders

521

1.56

3.46

2.0

1.7

471.61

316.74

mu/l

1.83

466

Type 1 diabetes, strict definition, subgroup 1

181

2362

0.75

3.46

1.5

1.7

294.62

290.51

mu/l

0.10

159

2150

Algoneurodystrophy

653

1.51

3.46

1.8

1.6

299.11

307.21

mu/l

0.08

592

Artrosis, including avohilmo

1872

9370

1.10

3.44

1.7

281.15

302.58

mu/l

1.83

1731

8525

Chondropathies

371

3062

1.22

3.41

1.6

1.7

283.60

296.37

mu/l

0.39

343

2780

Exophthalmic conditions

102

2.33

3.36

2.0

1.6

273.31

280.33

mu/l

0.06

Other and unspecified injuries of shoulder and upper arm

511

1.56

3.34

1.5

1.6

335.53

286.44

mu/l

0.51

465

Other chromosome abnormalities, not elsewhere classified

104

2.40

3.33

2.2

1.5

485.83

339.51

mu/l

0.73

Other acute viral hepatitis

235

1.86

3.33

1.7

1.6

422.29

285.69

mu/l

1.21

217

Gonarthrosis [arthrosis of knee](FG)

1134

5826

1.12

3.33

1.8

277.98

299.93

mu/l

1.75

1037

5343

Early onset COPD

264

2102

1.26

3.33

1.6

1.7

366.40

283.15

mu/l

2.21

236

1945

Striae atrophicae

243

1.85

3.33

1.5

1.7

242.28

285.09

mu/l

0.89

217

Antepartum haemorrhage, not elsewhere classified

383

3191

1.22

3.33

1.5

1.7

259.29

335.62

mu/l

9.52

336

2849

Embedded and impacted teeth

1390

10244

1.11

3.33

1.6

319.55

307.96

mu/l

0.23

1272

9177

Gingival hyperplasia

552

1.53

3.31

2.0

1.6

254.14

293.00

mu/l

1.51

506

Lung diseases due to external agents

148

1090

1.37

3.31

1.8

1.7

336.63

294.41

mu/l

0.59

140

1009

Other and unspecified injuries of abdomen, lower back and pelvis

295

1.75

3.31

1.4

1.6

237.42

286.60

mu/l

1.50

269

Other abnormal findings in urine

163

2.02

3.30

1.6

339.91

301.33

mu/l

0.30

147

Open wound of ankle and foot

250

1986

1.27

3.29

1.7

345.80

294.30

mu/l

1.32

231

1812

Other/unspecified enthesopathies of lower limb, excluding foot

161

1206

1.35

3.29

1.6

1.7

251.66

305.84

mu/l

3.25

153

1094

Malignant neoplasm, including Hilmo

1688

10747

0.91

3.29

1.9

1.7

298.69

298.47

mu/l

0.01

1592

9732

Alzheimer disease, excluding more controls

376

1.52

3.28

2.1

2.0

319.86

275.35

mu/l

0.46

354

Chronic pancreatitis

158

1178

1.35

3.28

2.1

1.7

349.03

280.29

mu/l

1.00

148

1104

Insulin, intermediate and long-acting

957

8207

1.13

3.28

1.7

314.44

289.61

mu/l

1.24

856

7525

Malignant neoplasm of bladder, including Hilmo

527

1.52

3.27

1.7

1.9

298.70

272.12

mu/l

0.32

487

Other and unspecified injuries of lower leg

226

1777

1.29

3.27

1.7

367.16

296.91

mu/l

1.74

209

1610

Disorders in reading

494

1.58

3.26

1.5

1.7

250.05

299.15

mu/l

1.84

441

Open wound of wrist and hand

1202

10469

1.11

3.26

1.7

319.23

297.95

mu/l

1.21

1086

9537

L02BA Anti-estrogens

134

1822

0.73

3.25

1.6

1.7

293.24

318.84

mu/l

0.54

121

1630

Other puerperal infections

416

3506

1.21

3.25

1.6

279.09

306.90

mu/l

0.95

369

3121

Diabetic maculopathy

171

2114

0.75

3.25

1.7

1.8

336.22

316.99

mu/l

0.22

149

1922

Overexertion and strenuous or repetitive movements

222

1742

1.29

3.24

1.7

268.94

286.36

mu/l

0.49

204

1595

Sarcoidosis

207

1610

1.30

3.20

2.0

1.7

312.26

293.16

mu/l

0.34

190

1473

Mental and behavioural disorders associated with the puerperium

323

1.73

3.20

1.5

1.6

421.76

300.53

mu/l

0.71

292

Superficial injury of ankle and foot

411

3452

1.20

3.20

1.6

1.7

287.88

299.89

mu/l

0.36

359

3124

Retinal breaks without detachment

195

1504

1.30

3.20

1.8

1.7

280.67

297.67

mu/l

0.44

184

1394

Vestibular neuronitis

134

980

1.38

3.18

1.9

1.6

294.63

296.43

mu/l

0.02

124

903

Other arthritis (FG)

627

5442

1.16

3.16

1.7

294.43

303.80

mu/l

0.34

583

4943

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

662

1.49

3.16

1.7

1.6

290.44

302.48

mu/l

0.19

595

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1452

11477

1.10

3.15

1.5

1.6

299.53

319.47

mu/l

0.43

1289

10248

Assault by unspecified means

480

1.57

3.15

1.8

1.7

302.97

274.40

mu/l

0.40

439

Exposure to other and unspecified animate mechanical forces

110

784

1.44

3.15

1.6

343.93

298.20

mu/l

0.43

101

709

Seropositive rheumatoid arthritis, strict definition

132

1788

0.73

3.14

1.6

1.7

280.16

302.44

mu/l

0.42

119

1622

Acute lymphocytic leukaemia

154

2.07

3.14

2.0

1.6

343.50

328.92

mu/l

0.08

147

Acute lymphocytic leukaemia, including Hilmo

154

2.07

3.14

2.0

1.6

343.50

328.92

mu/l

0.08

147

Acute lymphocytic leukaemia, helper endpoint

154

2.07

3.14

2.0

1.6

343.50

328.92

mu/l

0.08

147

Personal history of allergy to drugs, medicaments and biological substances

225

1.85

3.14

1.5

1.7

456.03

300.94

mu/l

0.67

206

Calcific tendinitis of shoulder

615

1.48

3.13

1.7

1.8

314.31

311.69

mu/l

0.03

566

Other respiratory disorders and diseases

207

1614

1.29

3.12

1.8

327.77

291.49

mu/l

0.96

190

1488

Other diseases of the respiratory system

207

1614

1.29

3.12

1.8

327.77

291.49

mu/l

0.96

190

1488

Other diseases of arteries and capillaries

134

984

1.37

3.10

1.9

1.7

315.60

299.17

mu/l

0.18

125

905

Obstructive hydrocephalus

160

1.99

3.10

2.6

1.5

317.74

301.87

mu/l

0.12

149

Unspecified acute lower respiratory infection

313

2566

1.23

3.09

1.6

1.7

312.73

285.60

mu/l

0.63

279

2355

Otitis media, unspecified

443

3460

1.19

3.09

1.7

318.26

324.82

mu/l

0.15

390

3139

Insulin, fast-acting (human)

260

3215

0.80

3.09

1.5

1.7

311.08

286.19

mu/l

0.48

226

2930

242

1.82

3.09

2.0

1.6

515.69

296.15

mu/l

0.98

221

Acute tubulo-interstitial nephritis

1421

10922

1.10

3.08

1.7

333.53

305.56

mu/l

1.54

1280

9847

Mental retardation, wide definition

110

779

1.43

3.08

2.1

1.6

511.38

294.71

mu/l

3.65

715

Diverticular disease of intestine

886

4883

1.13

3.07

1.8

272.17

292.01

mu/l

1.26

820

4467

Organic, including symptomatic, mental disorders

453

2689

1.19

3.07

2.2

1.8

385.60

287.76

mu/l

4.13

410

2481

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

624

5429

1.16

3.06

1.7

315.75

289.84

mu/l

0.89

574

4947

Hypermetropia

181

1394

1.31

3.06

1.9

1.6

285.12

310.99

mu/l

0.72

162

1266

Benign neoplasm of middle ear and respiratory system

106

750

1.43

3.06

1.8

1.7

300.65

287.72

mu/l

0.21

689

Mental retardation

108

763

1.43

3.06

2.1

1.6

512.08

296.76

mu/l

3.55

699

Malignant neoplasm, wide definition

1688

10701

0.91

3.06

1.9

1.7

298.34

298.62

mu/l

0.01

1592

9688

Ulcer of lower limb, not elsewhere classified

149

1114

1.34

3.05

1.8

1.7

445.43

293.83

mu/l

1.98

136

1029

Polyarthrosis

173

1188

1.32

3.03

1.8

1.9

273.35

342.66

mu/l

2.37

162

1100

Other and unspecified urticaria

528

4548

1.17

3.02

1.7

299.67

304.56

mu/l

0.10

479

4112

Oesophagitis

539

1.50

3.00

1.8

1.7

278.20

285.83

mu/l

0.09

501

Suppurative and unspecified otitis media

1443

11685

1.10

2.99

1.7

1.6

328.51

306.61

mu/l

1.26

1285

10566

Umbilical hernia

511

4389

1.17

2.99

1.6

1.7

295.88

290.52

mu/l

0.14

462

4012

Poisoning by medicine, drug-induced

221

1.83

2.99

1.3

1.6

281.80

289.35

mu/l

0.09

206

Medical abortion

1870

9327

1.09

2.99

1.6

1.7

310.81

328.93

mu/l

1.02

1660

8336

Hydrocephalus

539

1.50

2.98

2.4

1.6

478.99

292.84

mu/l

1.49

500

Injuries involving multiple body regions

691

1.45

2.96

1.8

1.6

337.25

284.75

mu/l

0.45

628

Melanocytic naevi of lower limb, including hip

112

809

1.41

2.95

1.6

351.71

296.21

mu/l

0.31

104

727

Infections with a predominantly sexual mode of transmission

1160

10493

1.11

2.94

1.6

294.72

308.23

mu/l

0.77

1051

9425

Other epidermal thickening

583

1.48

2.94

1.4

1.7

257.92

299.19

mu/l

1.07

531

Short stature, not elsewhere classified

574

1.48

2.94

1.7

1.5

412.47

316.73

mu/l

0.83

510

Delivery, wide proxy

988

4689

1.12

2.93

1.5

1.8

295.82

374.82

mu/l

10.52

885

4171

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

302

2481

1.23

2.93

1.8

1.7

311.60

294.67

mu/l

0.42

288

2256

Acute laryngitis and tracheitis

459

3864

1.18

2.93

1.6

1.7

302.69

311.57

mu/l

0.24

404

3504

Disorders of choroid and retina

1045

8126

0.90

2.93

1.8

319.70

292.28

mu/l

1.07

951

7440

Post-traumatic wound infection, not elsewhere classified

359

1.62

2.92

2.0

1.6

290.65

270.72

mu/l

0.37

331

Dislocation, sprain and strain of joints and ligaments of thorax

552

1.49

2.92

1.6

263.66

278.78

mu/l

0.31

505

Benign neoplasm: Stomach

104

740

1.42

2.92

2.1

1.7

309.19

313.05

mu/l

0.05

683

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

390

1.59

2.92

2.1

1.7

285.67

279.56

mu/l

0.07

354

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prolactin [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS